<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cell Mol Life Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell. Mol. Life Sci</journal-id>
<journal-title-group>
<journal-title>Cellular and Molecular Life Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1420-682X</issn>
<issn pub-type="epub">1420-9071</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30919020</article-id>
<article-id pub-id-type="pmc">6529381</article-id>
<article-id pub-id-type="publisher-id">3079</article-id>
<article-id pub-id-type="doi">10.1007/s00018-019-03079-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetics and the heart rate response to exercise</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>van de Vegte</surname>
<given-names>Yordi J.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Tegegne</surname>
<given-names>Balewgizie S.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verweij</surname>
<given-names>Niek</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snieder</surname>
<given-names>Harold</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>van der Harst</surname>
<given-names>Pim</given-names>
</name>
<address>
<email>p.van.der.harst@umcg.nl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9558 4598</institution-id><institution-id institution-id-type="GRID">grid.4494.d</institution-id><institution>Department of Cardiology, </institution><institution>University of Groningen, University Medical Center Groningen, </institution></institution-wrap>Hanzeplein 1, 9700 RB Groningen, The Netherlands </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9558 4598</institution-id><institution-id institution-id-type="GRID">grid.4494.d</institution-id><institution>Department of Genetics, </institution><institution>University of Groningen, University Medical Center Groningen, </institution></institution-wrap>9700 RB Groningen, The Netherlands </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9558 4598</institution-id><institution-id institution-id-type="GRID">grid.4494.d</institution-id><institution>Department of Epidemiology, </institution><institution>University of Groningen, University Medical Center Groningen, </institution></institution-wrap>9700 RB Groningen, The Netherlands </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.411737.7</institution-id><institution>Durrer Center for Cardiogenetic Research, </institution><institution>Netherlands Heart Institute, </institution></institution-wrap>3511 GC Utrecht, The Netherlands </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>27</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>76</volume>
<issue>12</issue>
<fpage>2391</fpage>
<lpage>2409</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The acute heart rate response to exercise, i.e., heart rate increase during and heart rate recovery after exercise, has often been associated with all-cause and cardiovascular mortality. The long-term response of heart rate to exercise results in favourable changes in chronotropic function, including decreased resting and submaximal heart rate as well as increased heart rate recovery. Both the acute and long-term heart rate response to exercise have been shown to be heritable. Advances in genetic analysis enable researchers to investigate this hereditary component to gain insights in possible molecular mechanisms underlying interindividual differences in the heart rate response to exercise. In this review, we comprehensively searched candidate gene, linkage, and genome-wide association studies that investigated the heart rate response to exercise. A total of ten genes were associated with the acute heart rate response to exercise in candidate gene studies. Only one gene (<italic>CHRM2</italic>), related to heart rate recovery, was replicated in recent genome-wide association studies (GWASs). Additional 17 candidate causal genes were identified for heart rate increase and 26 for heart rate recovery in these GWASs. Nine of these genes were associated with both acute increase and recovery of the heart rate during exercise. These genes can be broadly categorized into four categories: (1) development of the nervous system (<italic>CCDC141</italic>, <italic>PAX2</italic>, <italic>SOX5,</italic> and <italic>CAV2</italic>); (2) prolongation of neuronal life span (<italic>SYT10</italic>); (3) cardiac development (<italic>RNF220</italic> and <italic>MCTP2</italic>); (4) cardiac rhythm (<italic>SCN10A</italic> and <italic>RGS6</italic>). Additional 10 genes were linked to long-term modification of the heart rate response to exercise, nine with heart rate increase and one with heart rate recovery. Follow-up will be essential to get functional insights in how candidate causal genes affect the heart rate response to exercise. Future work will be required to translate these findings to preventive and therapeutic applications.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s00018-019-03079-4) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Heart rate increase</kwd>
<kwd>Heart rate recovery</kwd>
<kwd>Exercise</kwd>
<kwd>Genetics</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id>
<institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution>
</institution-wrap>
</funding-source>
<award-id>016.186.125</award-id>
<principal-award-recipient>
<name>
<surname>Verweij</surname>
<given-names>Niek</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Nature Switzerland AG 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">The regulation of resting heart rate is complex; autonomic tone, central and peripheral reflexes, hormonal influences, and factors intrinsic to the heart are all important determinants [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Despite recent developments in the understanding of the complex interplay of the plethora of biological mechanisms influencing resting heart rate [<xref ref-type="bibr" rid="CR3">3</xref>], our understanding is still incomplete.</p>
<p id="Par3">The acute heart rate response to exercise, heart rate increase during and heart rate recovery after exercise, offers unique insights into cardiac physiology compared to heart rate in rest and can therefore be exploited to obtain additional information on cardiac function [<xref ref-type="bibr" rid="CR4">4</xref>]. Impaired increase of heart rate during exercise (chronotropic incompetence) and an attenuated heart rate recovery have been associated with all-cause mortality and sudden cardiac death in healthy individuals [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>] and in those with cardiac disease, including individuals with heart failure [<xref ref-type="bibr" rid="CR8">8</xref>] and coronary artery disease [<xref ref-type="bibr" rid="CR9">9</xref>]. Regular endurance exercise training has been proven to shift the cardiac autonomic balance towards vagal dominance [<xref ref-type="bibr" rid="CR10">10</xref>]. The long-term response of heart rate to exercise results in favourable changes in chronotropic function, including decreased resting and submaximal heart rate as well as increased heart rate recovery [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p id="Par4">Both the acute and long-term responses of heart rate to exercise have been shown to have a large heritable component [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Development in the understanding of the human genome and genetic analysis enables researchers to investigate the possible molecular mechanisms underlying interindividual differences in the acute and long-term heart rate response to exercise [<xref ref-type="bibr" rid="CR18">18</xref>]. In this review, we summarize the current knowledge of the acute and long-term heart rate response to exercise, with a focus on the genetic contribution. In addition, we identify gaps in our knowledge and discuss possible future directions that might be of interest to enhance the understanding of the heart rate response to exercise and consider its potential clinical applications.</p>
</sec>
<sec id="Sec2">
<title>Acute response</title>
<sec id="Sec3">
<title>Heart rate increase</title>
<p id="Par5">In general, the regulation of the circulatory system during exercise involves several adaptations. These adaptations include dilatation of resistance vessels in the active muscles, a decrease in vagal outflow to the heart, followed by an increase of sympathetic outflow. If exercise is intense, the cholinergic fibers to the adrenal medulla are also activated, resulting in release of epinephrine into the circulation [<xref ref-type="bibr" rid="CR19">19</xref>]. Under normal physiological conditions, this results in increased venous return, contractility, and heart rate [<xref ref-type="bibr" rid="CR20">20</xref>]. In turn, ejection fraction increases due to a greater ejection of blood at the end of systole and increased diastolic filling of the ventricles as the duration of the systole decreases with increased heart rate [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
<p id="Par6">The increase of heart rate during exercise is for a major part attributable to the decrease in vagal tone followed by an increase in sympathetic outflow and an increase in levels of circulating catecholamines [<xref ref-type="bibr" rid="CR19">19</xref>]. It has been shown that a substantial component of interindividual differences in the heart rate increase during exercise is genetically determined, with heritability estimates ranging from 0.17 to 0.32 (Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. This suggests that genetic analyses may identify novel biological mechanisms involved in the regulation of heart rate response to exercise.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Heritability estimates for the acute and long-term effect of exercise on heart rate response</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Heritability type</th><th align="left">Heritability</th><th align="left">Type of exercise</th><th align="left">Population</th><th align="left">
<italic>N</italic>
</th><th align="left">Author, year</th></tr></thead><tbody><tr><td align="left" colspan="6">Acute response: heart rate increase</td></tr><tr><td align="left"> Family</td><td align="char" char=".">0.32</td><td align="left">Submaximal treadmill test</td><td align="left">General population</td><td align="char" char=".">2053</td><td align="left">Ingelsson et al. (2007) [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left"> SNP-based</td><td align="char" char=".">0.22</td><td align="left">Submaximal bicycle</td><td align="left">General population</td><td align="char" char=".">58,818</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left"> SNP-based</td><td align="char" char=".">0.17</td><td align="left">Submaximal bicycle</td><td align="left">General population</td><td align="char" char=".">66,800</td><td align="left">Ramirez J et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left" colspan="6">Acute response: heart rate recovery</td></tr><tr><td align="left"> Family<sup>a</sup></td><td align="char" char=".">0.34</td><td align="left">Submaximal treadmill test</td><td align="left">General population</td><td align="char" char=".">2053</td><td align="left">Ingelsson et al. (2007) [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left"> Twins and sibling<sup>b</sup></td><td align="left">0.60 and 0.65</td><td align="left">Maximal bicycle</td><td align="left">General population</td><td align="char" char=".">491</td><td align="left">Nederend et al. (2016) [<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td align="left"> SNP-based<sup>c</sup></td><td align="char" char=".">0.22</td><td align="left">Submaximal bicycle</td><td align="left">General population</td><td align="char" char=".">58,818</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left"> SNP-based<sup>c</sup></td><td align="char" char=".">0.12</td><td align="left">Submaximal bicycle</td><td align="left">General population</td><td align="char" char=".">66,665</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left" colspan="6">Trainings response: heart rate increase</td></tr><tr><td align="left"> Family<sup>d</sup></td><td align="char" char=".">0.34</td><td align="left">Submaximal bicycle</td><td align="left">General population</td><td align="char" char=".">481</td><td align="left">An et al. (2003) [<xref ref-type="bibr" rid="CR17">17</xref>]</td></tr><tr><td align="left"> Family<sup>d</sup></td><td align="char" char=".">0.36</td><td align="left">Submaximal bicycle</td><td align="left">Participants with high blood pressure</td><td align="char" char=".">529</td><td align="left">Rice et al. (2002) [<xref ref-type="bibr" rid="CR16">16</xref>]</td></tr></tbody></table><table-wrap-foot><p>Heritability estimates for the acute and long-term effect of exercise on heart rate response</p><p><sup>a</sup>Heart rate recovery measured after 180 s</p><p><sup>b</sup>Heart rate recovery measured after, respectively, 60 and 180 s</p><p><sup>c</sup>Heart rate recovery measured after 60 s</p><p><sup>d</sup>20 weeks during endurance training program at submaximal (50W) levels</p></table-wrap-foot></table-wrap></p>
<p id="Par7">Several studies have focussed on identifying genetic determinants that explain interindividual differences in heart rate increase during exercise. Genes investigated in these studies are summarized in Table <xref ref-type="table" rid="Tab2">2</xref>, shown in Fig. <xref ref-type="fig" rid="Fig1">1</xref>, and are further discussed here. The <italic>ACE</italic> gene was one of the first candidate genes thoroughly investigated for its possible relationship with the heart rate response to exercise [<xref ref-type="bibr" rid="CR21">21</xref>]. Genetic association studies focusing on the effect of the <italic>ACE</italic> gene on heart rate increase during exercise reported many conflicting results [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR25">25</xref>]. Some studies tested genes for their indirect effect on the sympathetic nervous system. One study observed that the <italic>NOS3</italic> gene, which produces nitric oxide, was associated with heart rate increase during exercise [<xref ref-type="bibr" rid="CR26">26</xref>]. Although nitric oxide is mostly known for its vasodilatory effects, it is also thought to have a modulating effect on the parasympathetic and sympathetic nervous system [<xref ref-type="bibr" rid="CR27">27</xref>]. <italic>GNAS1</italic> was found to be associated with heart rate increase during exercise as well [<xref ref-type="bibr" rid="CR28">28</xref>]. This gene encodes the G protein α-subunit that influences the sympathetic nervous system as it enables the coupling between adenylyl cyclase and β1-adrenergic receptors. On the other hand, many studies brought forward genes based on their direct involvement in the sympathetic nervous system, and associations were found with the <italic>ADRB1</italic> [<xref ref-type="bibr" rid="CR29">29</xref>] and <italic>ADRB2</italic> [<xref ref-type="bibr" rid="CR30">30</xref>] genes, which both encode for β-adrenergic receptors. Interestingly, many previous findings could not be replicated in the Framingham Offspring study, which investigated multiple genes instead of focusing on a single gene. In this study, associations were found with the <italic>ADRA1A</italic> and <italic>ADRA1D</italic> [<xref ref-type="bibr" rid="CR12">12</xref>]. These genes encode for α-adrenergic receptors that are mainly involved in smooth muscle cell contraction during sympathetic stimulation [<xref ref-type="bibr" rid="CR12">12</xref>]. However, associations with the <italic>ADRB1</italic> and <italic>ADRB2</italic> genes could not be re-established [<xref ref-type="bibr" rid="CR12">12</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of genes involved in acute heart rate increase</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">Variant</th><th align="left">Chromosome/position</th><th align="left">Minor/major allele/MAF</th><th align="left">Type of study</th><th align="left">Increase/decrease</th><th align="left"><italic>P</italic> value</th><th align="left">Type of exercise test</th><th align="left">Population</th><th align="left">Author; year</th></tr></thead><tbody><tr><td align="left">
<italic>ACE</italic>
<sup>a</sup>
</td><td align="left">Del intron 16</td><td align="left">17:63488529</td><td align="left">Deletion/insertion </td><td align="left">Candidate</td><td align="left">–</td><td align="left">&gt; 5.00 × 10<sup>−2</sup></td><td align="left">Maximal and submaximal bicycle</td><td align="left">General</td><td align="left">Rankinen et al. (2000) [<xref ref-type="bibr" rid="CR25">25</xref>]</td></tr><tr><td align="left">
<italic>ADRA1A</italic>
</td><td align="left">rs544215</td><td align="left">8:26712028</td><td align="left">C/T/0.46</td><td align="left">Candidate</td><td align="left">↓</td><td align="left">5.00 × 10<sup>−3</sup></td><td align="left">Standard Bruce</td><td align="left">General</td><td align="left">Ingelsson et al. (2007) [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left">
<italic>ADRA1D</italic>
</td><td align="left">rs3787441</td><td align="left">20:4205059</td><td align="left">G/A/0.27</td><td align="left">Candidate</td><td align="left">↓</td><td align="left">7.00 × 10<sup>−3</sup></td><td align="left">Standard Bruce</td><td align="left">General</td><td align="left">Ingelsson et al. (2007) [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left">
<italic>ADRB1</italic>
</td><td align="left">rs1801253</td><td align="left">10:114045297</td><td align="left">C/G/0.28</td><td align="left">Candidate</td><td align="left">↓</td><td align="left">&lt; 5.00 × 10<sup>−2</sup></td><td align="left">Maximal</td><td align="left">Patients in cardiac rehab</td><td align="left">Defoor et al. (2005) [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td align="left">
<italic>ADRB1</italic>
</td><td align="left">rs1801252</td><td align="left">10:114044277</td><td align="left">G/A/0.21</td><td align="left">Candidate</td><td align="left">↓</td><td align="left">&lt; 5.00 × 10<sup>−2</sup></td><td align="left">Maximal</td><td align="left">Patients in cardiac rehab</td><td align="left">Defoor et al. (2005) [<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td align="left">
<italic>ADRB2</italic>
</td><td align="left">rs1042713</td><td align="left">5:148826877</td><td align="left">A/G/-</td><td align="left">Candidate</td><td align="left">↓</td><td align="left">&lt; 5.00 × 10<sup>−2</sup></td><td align="left">Hand grip test</td><td align="left">General</td><td align="left">Eisenach et al.(2003)[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td align="left">
<italic>CAV2</italic>
</td><td align="left">rs28495552</td><td align="left">7:116113744</td><td align="left">C/G/0.50</td><td align="left">GWAS</td><td align="left">↓</td><td align="left">2.80 × 10<sup>−11</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>CCDC141</italic>
</td><td align="left">rs10497529</td><td align="left">2:179839888</td><td align="left">A/G/0.04</td><td align="left">GWAS</td><td align="left">↑</td><td align="left">2.50 × 10<sup>−9</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>GNAS1</italic>
<sup>b</sup>
</td><td align="left">rs7121</td><td align="left">20:58903752</td><td align="left">C/T/0.37</td><td align="left">Candidate</td><td align="left">↑</td><td align="left">&lt;5.00 × 10<sup>−2</sup></td><td align="left">Ergometer</td><td align="left">Referred for exercise test</td><td align="left">Nieminen et al. (2006) [<xref ref-type="bibr" rid="CR28">28</xref>]</td></tr><tr><td align="left">
<italic>HMGA2</italic>
</td><td align="left">rs1480470</td><td align="left">12:66412130</td><td align="left">A/G/0.37</td><td align="left">GWAS </td><td align="left">↑</td><td align="left">3.40 × 10<sup>−08</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>MCTP2</italic>
</td><td align="left">rs12906962</td><td align="left">15:95312071</td><td align="left">C/T/0.32</td><td align="left">GWAS </td><td align="left">↓</td><td align="left">3.50 × 10<sup>−13</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>MCTP2</italic>
</td><td align="left">rs12906962</td><td align="left">15:95312071</td><td align="left">C/T/0.33</td><td align="left">GWAS </td><td align="left">↓</td><td align="left">2.70 × 10<sup>−14</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">
<italic>NOLA</italic>
<sup>c,d</sup>
</td><td align="left">rs6847149</td><td align="left">4:111157701</td><td align="left">–</td><td align="left">GWAS </td><td align="left">–</td><td align="left">2.74 × 10<sup>−06</sup></td><td align="left">Standard Bruce</td><td align="left">General</td><td align="left">Vasan et al. (2007) [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td align="left">
<italic>NOS3</italic>
<sup>e</sup>
</td><td align="left">rs1799983</td><td align="left">7:150999023</td><td align="left">T/G/0.26</td><td align="left">Candidate</td><td align="left">↓</td><td align="left">4.00  × 10<sup>−2</sup></td><td align="left">Naughton protocol</td><td align="left">Post-menopausal women</td><td align="left">Hand et al. (2006) [<xref ref-type="bibr" rid="CR26">26</xref>]</td></tr><tr><td align="left">
<italic>PAX2</italic>
</td><td align="left">rs11190709</td><td align="left">10:102552663</td><td align="left">G/A/0.12</td><td align="left">GWAS </td><td align="left">↑</td><td align="left">1.30 × 10<sup>−11</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>POP4</italic>
</td><td align="left">rs12986417</td><td align="left">19:30109533</td><td align="left">A/G/0.35</td><td align="left">GWAS </td><td align="left">↓</td><td align="left">1.00 × 10<sup>−9</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">
<italic>POP4</italic>
</td><td align="left">rs7255293</td><td align="left">19:30104198</td><td align="left">G/A/0.42</td><td align="left">GWAS </td><td align="left">↓</td><td align="left">3.20 × 10<sup>−9</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al.(2018)[<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>PPIL1</italic>
</td><td align="left">rs236352</td><td align="left">6:36817113</td><td align="left">A/G/0.34</td><td align="left">GWAS </td><td align="left">↑</td><td align="left">6.40 × 10<sup>−10</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>RGS6</italic>
</td><td align="left">rs17180489</td><td align="left">14:72885471</td><td align="left">C/G/0.14</td><td align="left">GWAS</td><td align="left">↑</td><td align="left">2.50 × 10<sup>−11</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">
<italic>RNF220</italic>
</td><td align="left">rs272564</td><td align="left">1:45012273</td><td align="left">C/A/0.28</td><td align="left">GWAS</td><td align="left">↓</td><td align="left">7.40 × 10<sup>−12</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>RP1L1</italic>
</td><td align="left">rs58065122</td><td align="left">8:10526186</td><td align="left">A/G/0.42</td><td align="left">GWAS</td><td align="left">↑</td><td align="left">3.90 × 10<sup>−10</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>RYR2</italic>
<sup>c,d</sup>
</td><td align="left">rs2819770</td><td align="left">1:234237045</td><td align="left">–</td><td align="left">GWAS</td><td align="left">–</td><td align="left">3.53 × 10<sup>−6</sup></td><td align="left">Standard Bruce</td><td align="left">General</td><td align="left">Vasan et al. (2007) [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td align="left">
<italic>SCN10A</italic>
</td><td align="left">rs7433723</td><td align="left">3:38784957</td><td align="left">G/A/0.42</td><td align="left">GWAS</td><td align="left">↓</td><td align="left">4.50 × 10<sup>−8</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>SNCAIP</italic>
</td><td align="left">rs4836027</td><td align="left">5:121866990</td><td align="left">C/T/0.32</td><td align="left">GWAS</td><td align="left">↓</td><td align="left">1.70 × 10<sup>−15</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">
<italic>SNCA1P</italic>
</td><td align="left">rs4836027</td><td align="left">5:121866990</td><td align="left">C/T/0.31</td><td align="left">GWAS</td><td align="left">↓</td><td align="left">9.90 × 10<sup>−21</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>SOX5</italic>
</td><td align="left">rs4246224</td><td align="left">12:24784139</td><td align="left">A/G/0.15</td><td align="left">GWAS</td><td align="left">↑</td><td align="left">1.80 × 10<sup>−14</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>SYT10</italic>
</td><td align="left">rs1343676</td><td align="left">12:33537387</td><td align="left">T/C/0.51</td><td align="left">GWAS</td><td align="left">↓</td><td align="left">1.50 × 10<sup>−11</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">
<italic>TCF4</italic>
</td><td align="left">rs1125313</td><td align="left">18:52859261</td><td align="left">C/A/0.50</td><td align="left">GWAS</td><td align="left">↑</td><td align="left">3.90 × 10<sup>−9</sup></td><td align="left">Submaximal bicycle</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr></tbody></table><table-wrap-foot><p>Genes found to be associated with heart rate increase during exercise are shown in alphabetical order and are then ordered on the year published. Variation stands for either an SNP or deletion/insertion mutation. MAF stands for Minor Allele Frequency. Effects of a variant (in- or decrease) on heart rate increase during exercise are shown for the Minor Allele. Candidate stands for candidate gene study. GWAS stands for genome-wide association study. A hyphen is shown in case information which was not reported</p><p><sup>a</sup>Results from only one candidate gene study on ACE are shown; largest study was chosen; G allele in case of deletion; in case of insertion ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC</p><p><sup>b</sup>Statistics from gene time of exercise interaction are showed</p><p><sup>c</sup>Standard Bruce protocol is a maximal exercise treadmill test</p><p><sup>d</sup>Statistics from the generalized estimating equations (GEE) tests are shown; Alleles were not mentioned in this article. None reached genome-wide significance; however, these were the most suggestive results</p><p><sup>e</sup>Naughton protocol is a maximal exercise treadmill test</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Graphical representation of genes (shown in italic) involved in acute heart rate increase during exercise grouped by working mechanism (shown in bold). The left and left upper part of the figure shows the nervous system. The middle upper part zooms in on a peripheral sympathetic neuron and its synapse. The heart is displayed on the right; the upper right of the figure shows the aorta with next to it a pacemaker cell in the cardiac sinus node. In the middle of the figure, below, we zoom in on cardiac tissue and receptors. Adrenergic receptors are shown in red. Sodium, potassium, and calcium channels are shown in red, pink, and green, respectively</p></caption><graphic id="MO1" xlink:href="18_2019_3079_Fig1_HTML"></graphic></fig></p>
<p id="Par8">Although these studies were important for laying the foundation of our knowledge on the genetic determinants of heart rate increase during exercise, they failed to yield a comprehensive view by focusing on one or only a few genes. The Framingham Offspring study was the first to address these issues by conducting an early genetic linkage analysis on heart rate increase and recovery. However, not one genetic signal reached the appropriate significance level, which can possibly be attributed to the relatively low sample size of this study (<italic>n </italic> = 2982) [<xref ref-type="bibr" rid="CR12">12</xref>]. In addition, linkage analyses have been shown to be less successful when applied to polygenic traits such as heart rate response to exercise [<xref ref-type="bibr" rid="CR31">31</xref>], in part because of their limited power to detect the effect of common alleles with modest effects on disease [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
<p id="Par9">More recently, genome-wide association studies (GWASs) were introduced. GWASs do have the potential to detect common alleles with modest effects on disease, since this method allows an unbiased and comprehensive search across the genome for single nucleotide polymorphisms (SNPs) [<xref ref-type="bibr" rid="CR33">33</xref>]. The first GWAS on heart rate increase during exercise found <italic>GAR1</italic> and <italic>RYR2</italic> genes to be associated [<xref ref-type="bibr" rid="CR34">34</xref>]. <italic>GAR1</italic> is required for ribosome biogenesis and telomere maintenance. However, its specific function and how it possibly interacts with heart rate increase during exercise is unknown. <italic>RYR2</italic> encodes a calcium channel that mediates calcium release from the sarcoplasmic reticulum into the cytoplasm and is therefore essential in triggering cardiac muscle contraction (Table <xref ref-type="table" rid="Tab2">2</xref>, Fig. <xref ref-type="fig" rid="Fig1">1</xref>). <italic>RYR2</italic> mutations in humans are associated with arrhythmogenic right-ventricular dysplasia and catecholaminergic polymorphic ventricular tachycardia. Interestingly, although caused by a different mutation in the <italic>RYR2</italic> gene, both diseases are known to cause exercise-induced tachycardia [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref>]. However, these associations did not reach genome-wide significance, which might be due to the low sample size (<italic>n</italic> = 1238) [<xref ref-type="bibr" rid="CR34">34</xref>].</p>
<p id="Par10">Increasing the sample size for GWASs has been simplified by the development of inexpensive SNP arrays. Two GWASs were recently conducted on the acute heart rate response to exercise in the same cohort of the UK Biobank [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The discussion of methodological differences between these studies has been published previously [<xref ref-type="bibr" rid="CR38">38</xref>] and is beyond the scope of the current review. However, a summary of important differences is necessary to understand different genes found between the two studies. One difference is that the first study by Verweij et al. had a slightly lower sample size, since they used only echocardiography (ECG) measurements and did not include heart rate measurements derived by the UK Biobank itself. Another difference is that the study of Verweij et al. applied a more stringent threshold to claim a genome-wide significant level to be true (strategy to reduce the risk of type-1 errors) compared to the study published later by Ramirez et al. (<italic>p</italic> &lt; 8.3 × 10<sup>−9</sup> vs <italic>p</italic> &lt; 5.0 × 10<sup>−8</sup>, respectively).</p>
<p id="Par11">Of special interest are three genes that were found to be associated with heart rate increase during exercise in both studies, which are <italic>SNCAIP, MCTP2,</italic> and <italic>POP4</italic> [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The exact mechanism of <italic>SCNAIP</italic> is not known so far; however, studies in mice have shown that <italic>SCNAIP</italic> plays a role in neuronal degeneration (Table <xref ref-type="table" rid="Tab2">2</xref>, Fig. <xref ref-type="fig" rid="Fig1">1</xref>) [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. <italic>POP4</italic> is involved in the processing of precursor RNAs [<xref ref-type="bibr" rid="CR41">41</xref>] and in the DNA damage response [<xref ref-type="bibr" rid="CR42">42</xref>], thus preventing accumulation of deleterious mutations and DNA lesions and therefore potentially preventing genomic instabilities and carcinogenesis and prolonging neuronal life span. The <italic>MCTP2</italic> gene is more specific to cardiac tissue. A mutation in the <italic>MCTP2</italic> is known to cause left-ventricular outflow tract malformations in humans, which may alter the pressure within the ventricular outflow tract. Baroreceptors are densely located in this region and altered blood pressure could therefore lead to altered autonomic feedback on heart rate (Table <xref ref-type="table" rid="Tab2">2</xref>, Fig. <xref ref-type="fig" rid="Fig1">1</xref>) [<xref ref-type="bibr" rid="CR43">43</xref>]. Several other candidate genes found in these studies already provide a biological hypothesis to account for the associations with heart rate response to exercise. These genes can be broadly categorized into four categories, that is: (1) development of the nervous system, including the <italic>CCDC141</italic> [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], <italic>TCF4</italic> [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]<italic>, PAX2</italic> [<xref ref-type="bibr" rid="CR48">48</xref>]<italic>, SOX5</italic> [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>], and <italic>CAV2</italic> [<xref ref-type="bibr" rid="CR51">51</xref>] genes; (2) prolongation of neuronal life span, including the <italic>SYT10</italic> [<xref ref-type="bibr" rid="CR52">52</xref>] gene; (3) cardiac development and disease, including RNF220 [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] gene; and, finally, (4) genes involved in cardiac rhythm, including <italic>SCN10A</italic> [<xref ref-type="bibr" rid="CR55">55</xref>] and <italic>RGS6</italic> [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Of these, <italic>CCDC141, CAV2</italic>, <italic>SYT10, RNF220,</italic> and <italic>SCN10A</italic> were more strongly associated with heart rate recovery after exercise (Tables <xref ref-type="table" rid="Tab2">2</xref>, <xref ref-type="table" rid="Tab3">3</xref>) and will be therefore discussed later. <italic>TCF4</italic> is involved in the initiation of neuronal differentiation. Clinically, a mutation in <italic>TCF4</italic> is known to cause Pitt-Hopkins syndrome, a severe congenital encephalopathy characterized by intellectual disability, developmental problems, seizures, breathing problems, and typical facial features [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. <italic>PAX2</italic> encodes paired box gene 2 and is important in the early embryonic development as well. It is mostly known for its involvement in development of the kidney and urinary tract, since it is linked to papillorenal syndrome [<xref ref-type="bibr" rid="CR58">58</xref>] and focal segmental glomerulosclerosis [<xref ref-type="bibr" rid="CR59">59</xref>]. However, downstream target effectors of <italic>PAX2</italic> have been hypothesized to be involved in neuronal development because of their supposed effect on the CHARGE syndrome [<xref ref-type="bibr" rid="CR48">48</xref>]. <italic>SOX5</italic> is involved in the regulation of chondrogenesis and the development of the nervous system [<xref ref-type="bibr" rid="CR50">50</xref>]. In mice, it was found that loss of <italic>SOX5</italic> resulted in decreased neuronal differentiation and secondary migrational abnormalities [<xref ref-type="bibr" rid="CR49">49</xref>]. Mutations of the <italic>SOX5</italic> gene in humans are known to cause the Lamb–Shaffer syndrome, which is characterized by speech delay, behavioural problems, and nonspecific dysmorphic features [<xref ref-type="bibr" rid="CR50">50</xref>]. <italic>RGS6</italic> is part of the regulation mechanism of the parasympathetic nervous system in the heart [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. It decreases muscarinic type 2 receptor (M2R) signalling in the sinoatrial node by rapidly terminating Gβγ signalling [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. In mice, it was shown that <italic>RGS6</italic> knockdown removes the negative regulation of Gβγ leading to enhanced G protein-coupled inwardly rectifying potassium channel (GIRK)-induced sinoatrial and atrioventricular node hyperpolarization [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. It was therefore concluded that normal function of <italic>RGS6</italic> is important for preventing parasympathetic override and severe bradycardia [<xref ref-type="bibr" rid="CR56">56</xref>]. Its involvement in the parasympathetic nervous system was recently established in another GWAS in which it was found to be associated with heart rate variability [<xref ref-type="bibr" rid="CR60">60</xref>], which is known to reflect parasympathetic activity [<xref ref-type="bibr" rid="CR61">61</xref>]. Concerning heart rate increase during exercise, normal function of <italic>RGS6</italic> probably facilitates parasympathetic withdrawal leading to the possibility to increase heart rate (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Summary of genes involved in acute heart rate recovery</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">Variant</th><th align="left">Chromosome/position</th><th align="left">Minor/major allele/MAF</th><th align="left">Increase/decrease</th><th align="left"><italic>P</italic> value</th><th align="left">Type of study</th><th align="left">Type of exercise test</th><th align="left">Time (seconds after exercise)</th><th align="left">Population</th><th align="left">Author; year</th></tr></thead><tbody><tr><td align="left">ACE</td><td align="left">–</td><td align="left">–</td><td align="left">Deletion/insertion </td><td align="left">–</td><td align="left">&lt; 1.00 × 10<sup>−2</sup></td><td align="left">Candidate</td><td align="left">Running for 25 min with heart rate between 165 and 170</td><td align="char" char=".">1800</td><td align="left">Athletes</td><td align="left">Voroshin et al. (2008) [<xref ref-type="bibr" rid="CR22">22</xref>]</td></tr><tr><td align="left">ACHE</td><td align="left">rs3757868</td><td align="left">7:100482720</td><td align="left">A/G/0.18</td><td align="left">↓</td><td align="left">5.60 × 10<sup>−24</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">40</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">ACHE</td><td align="left">rs3757868</td><td align="left">7:100482720</td><td align="left">A/G/0.18</td><td align="left">↓</td><td align="left">6.90 × 10<sup>−11</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">ADRA1B<sup>a</sup></td><td align="left">rs11953285</td><td align="left">5:159324389</td><td align="left">C/A/0.13</td><td align="left">↑</td><td align="left">1.00 × 10<sup>−2</sup></td><td align="left">Candidate</td><td align="left">Standard Bruce<sup>b</sup></td><td align="char" char=".">180</td><td align="left">General</td><td align="left">Ingelsson et al. (2007) [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left">ADRA2B<sup>c</sup></td><td align="left">del301–303</td><td align="left">2:96115249</td><td align="left">./AAGAGGAG/0.37</td><td align="left">↓</td><td align="left">1.00 × 10<sup>−2</sup></td><td align="left">Candidate</td><td align="left">Maximal bicycle</td><td align="char" char=".">60</td><td align="left">General</td><td align="left">Kohli et al. (2015) [<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td align="left">ALG10B</td><td align="left">rs4533105</td><td align="left">12:38214611</td><td align="left">C/T/0.43</td><td align="left">↓</td><td align="left">1.90 × 10<sup>−13</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">BCAT1 </td><td align="left">rs4963772</td><td align="left">12:24758480</td><td align="left">A/G/0.15</td><td align="left">↑</td><td align="left">1.20 × 10<sup>−28</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">40</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">BCL11A</td><td align="left">rs1372876</td><td align="left">2:60025963</td><td align="left">A/C/0.41</td><td align="left">↓</td><td align="left">3.30 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">CAV2</td><td align="left">rs1997571</td><td align="left">7:116198621</td><td align="left">G/A/0.48</td><td align="left">↓</td><td align="left">1.70 × 10<sup>−12</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">20</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">CAV2</td><td align="left">rs2109514</td><td align="left">7:116159961</td><td align="left">A/G/0.50</td><td align="left">↑</td><td align="left">7.10 × 10<sup>−10</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">CCDC141,TTN</td><td align="left">rs17362588</td><td align="left">2:179721046</td><td align="left">A/G/0.08</td><td align="left">↓</td><td align="left">3.10 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">10</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">CCDC141,TTN</td><td align="left">rs35596070</td><td align="left">2:179759692</td><td align="left">A/C/0.14</td><td align="left">↓</td><td align="left">4.20 × 10<sup>−13</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">10</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">CHRM2</td><td align="left">rs324640</td><td align="left">7:136146251</td><td align="left">C/T/0.39</td><td align="left">↓</td><td align="left">8.00 × 10<sup>−3</sup></td><td align="left">Candidate</td><td align="left">Maximal bicycle</td><td align="char" char=".">60</td><td align="left">General</td><td align="left">Hautala (2006) [<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td align="left">CHRM2</td><td align="left">rs8191992</td><td align="left">7:136158563</td><td align="left">A/T/0.37</td><td align="left">↓</td><td align="left">2.50 × 10<sup>−3</sup></td><td align="left">Candidate</td><td align="left">Maximal bicycle</td><td align="char" char=".">60</td><td align="left">General</td><td align="left">Hautala (2006) [<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td align="left">CHRM2<sup>d</sup></td><td align="left">rs324640</td><td align="left">7:136146251</td><td align="left">C/T/0.44</td><td align="left">↓</td><td align="left">1.70 × 10<sup>−3</sup></td><td align="left">Candidate</td><td align="left">Symptom-limited maximal bicycle</td><td align="char" char=".">60</td><td align="left">Post-MI</td><td align="left">Hautala (2009) [<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td align="left">CHRM2<sup>d</sup></td><td align="left">rs8191992</td><td align="left">7:136158563</td><td align="left">A/T/0.43</td><td align="left">↓</td><td align="left">1.60 × 10<sup>−3</sup></td><td align="left">Candidate</td><td align="left">Symptom-limited maximal bicycle</td><td align="char" char=".">60</td><td align="left">Post-MI</td><td align="left">Hautala (2009) [<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td align="left">CHRM2</td><td align="left">rs17168815</td><td align="left">7:136624621</td><td align="left">T/G/0.16</td><td align="left">↓</td><td align="left">1.10 × 10<sup>−14</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">CHRM2</td><td align="left">rs6943656</td><td align="left">7:136639436</td><td align="left">G/A/0.16</td><td align="left">↓</td><td align="left">2.30 × 10<sup>−10</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">CLPB, INPPL1</td><td align="left">rs7130652</td><td align="left">11:71984398</td><td align="left">T/G/0.07</td><td align="left">↑</td><td align="left">3.40 × 10<sup>−11</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">10</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">CNTN3 </td><td align="left">rs34310778</td><td align="left">3:74783408</td><td align="left">C/T/0.43</td><td align="left">↑</td><td align="left">1.00 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">30</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">CNTN3</td><td align="left">rs6549649</td><td align="left">3:74786491</td><td align="left">C/G/0.64</td><td align="left">↑</td><td align="left">1.40 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">GNG11</td><td align="left">rs180238</td><td align="left">7:93550447</td><td align="left">C/T/0.35</td><td align="left">↓</td><td align="left">2.20 × 10<sup>−12</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">40</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">GRIK2 </td><td align="left">rs2224202</td><td align="left">6:102053814</td><td align="left">A/G/0.19</td><td align="left">↑</td><td align="left">5.80 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">20</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">KCNH8 </td><td align="left">rs73043051</td><td align="left">3:18883863</td><td align="left">C/T/0.22</td><td align="left">↑</td><td align="left">7.80 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">MCTP2</td><td align="left">rs12906962</td><td align="left">15:95312071</td><td align="left">C/T/0.32</td><td align="left">↓</td><td align="left">5.10 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">MED13L </td><td align="left">rs61928421</td><td align="left">12:116227249</td><td align="left">T/C/0.07</td><td align="left">↓</td><td align="left">4.30 × 10<sup>−15</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">40</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">MED13L </td><td align="left">rs11067773</td><td align="left">12:11622895</td><td align="left">C/T/0.09</td><td align="left">↓</td><td align="left">3.10 × 10<sup>−11</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">NDUFA11</td><td align="left">rs12974440</td><td align="left">19:5894386</td><td align="left">A/G/0.08</td><td align="left">↓</td><td align="left">2.40 × 10<sup>−10</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">10</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">NDUFA11</td><td align="left">rs12974991</td><td align="left">19:5894584</td><td align="left">A/G/0.09</td><td align="left">↓</td><td align="left">2.10 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">NEGR1 </td><td align="left">rs61765646</td><td align="left">1:72723211</td><td align="left">A/T/0.19</td><td align="left">↑</td><td align="left">1.10 × 10<sup>−13</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">10</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">PAX2</td><td align="left">rs4917911</td><td align="left">10:102559421</td><td align="left">G/A/0.11</td><td align="left">↑</td><td align="left">6.60 × 10<sup>−15</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">PAX2 </td><td align="left">rs7072737</td><td align="left">10:102552663</td><td align="left">G/A/0.11</td><td align="left">↑</td><td align="left">1.10 × 10<sup>−17</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">40</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">PRDM6</td><td align="left">rs151283</td><td align="left">5:122446619</td><td align="left">A/C/0.28</td><td align="left">↓</td><td align="left">1.60 × 10<sup>−10</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">PRKAG2<sup>e</sup></td><td align="left">rs1029947</td><td align="left">7:150713400</td><td align="left">–</td><td align="left">–</td><td align="left">9.20 × 10<sup>−7</sup></td><td align="left">GWAS</td><td align="left">Standard Bruce<sup>b</sup></td><td align="char" char=".">180</td><td align="left">General</td><td align="left">Vasan et al. (2007) [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td align="left">PRKAG2<sup>e</sup></td><td align="left">rs1029946</td><td align="left">7:150713454</td><td align="left">–</td><td align="left">–</td><td align="left">3.89 × 10<sup>−6</sup></td><td align="left">GWAS</td><td align="left">Standard Bruce<sup>b</sup></td><td align="char" char=".">180</td><td align="left">General</td><td align="left">Vasan et al. (2007) [<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td align="left">RGS6</td><td align="left">rs150330648</td><td align="left">14:72844765</td><td align="left">T/G/0.01</td><td align="left">↓</td><td align="left">4.30 × 10<sup>−8</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">RNF220</td><td align="left">rs272564</td><td align="left">1:45012273</td><td align="left">C/A/0.29</td><td align="left">↓</td><td align="left">1.40 × 10<sup>−12</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">RNF220</td><td align="left">rs272564</td><td align="left">1:45012273</td><td align="left">C/A/0.28</td><td align="left">↓</td><td align="left">8.80 × 10<sup>−10</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">SCN10A</td><td align="left">rs6795970</td><td align="left">3:38766675</td><td align="left">A/G/0.40</td><td align="left">↓</td><td align="left">2.60 × 10<sup>−8</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">SERINC2</td><td align="left">rs11589125</td><td align="left">1:31894396</td><td align="left">T/C/0.06</td><td align="left">↑</td><td align="left">6.60 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">SKAP </td><td align="left">rs2158712</td><td align="left">7:26582733</td><td align="left">T/A/0.48</td><td align="left">↓</td><td align="left">2.80 × 10<sup>−13</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">10</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">SNCAIP</td><td align="left">rs1993875</td><td align="left">5:121869310</td><td align="left">C/G/0.30</td><td align="left">↓</td><td align="left">9.50 × 10<sup>−9</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">SOX5</td><td align="left">rs112630705</td><td align="left">12:24773919</td><td align="left">A/G/0.15</td><td align="left">↑</td><td align="left">3.20 × 10<sup>−11</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">SYT10</td><td align="left">rs6488162</td><td align="left">12:33593127</td><td align="left">T/C/0.42</td><td align="left">↓</td><td align="left">2.60 × 10<sup>−66</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">10</td><td align="left">General</td><td align="left">Verweij et al. (2018) [<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left">SYT10</td><td align="left">rs2218650</td><td align="left">12: 33734783</td><td align="left">A/G/0.15</td><td align="left">↓</td><td align="left">1.10 × 10<sup>−26</sup></td><td align="left">GWAS</td><td align="left">Submaximal bicycle</td><td align="char" char=".">50</td><td align="left">General</td><td align="left">Ramirez et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr></tbody></table><table-wrap-foot><p>Genes found to be associated with heart rate recovery after exercise are shown in alphabetical order and are then ordered on the year published. Mutation stands for either a SNP or deletion/insertion mutation. MAF stands for Minor Allele Frequency. Effect of variant (increase or decrease) on heart rate increase during exercise is shown for the minor allele. Candidate stands for candidate gene study. GWAS stands for genome-wide association study. MI stands for myocardial infarction. A hyphen is shown in case information which was not reported</p><p><sup>a</sup>Insignificant after correction for multiple testing</p><p><sup>b</sup>Standard Bruce protocol was used</p><p><sup>c</sup>Heart rate recovery constant was used as measurement. This fits heart rate recovery to a first-order exponential decay curve</p><p><sup>d</sup>Compared lowest and highest HRR quartile. Linear model showed no significant association</p><p><sup>e</sup>Statistics from the family-based association tests are shown; Alleles were not mentioned in this article. None reached genome-wide significance. Results shown are the strongest associations</p></table-wrap-foot></table-wrap></p>
<p id="Par12">Interestingly, none of the genes investigated in candidate gene studies were found to be associated with heart rate increase in any of the three GWASs. This is in line with the previous work in which early candidate gene studies were difficult to replicate [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Two genes, <italic>HMGA2</italic> and <italic>PPIL1</italic>, shown in Table <xref ref-type="table" rid="Tab2">2</xref> have not been discussed so far. <italic>PPIL1</italic> is a gene that was recently found to be associated with heart rate variability as well [<xref ref-type="bibr" rid="CR60">60</xref>]. However, to our knowledge, there is no current biological hypothesis to explain the association between <italic>PPIL1</italic> or <italic>HMGA2</italic> and heart rate increase during exercise.</p>
</sec>
<sec id="Sec4">
<title>Heart rate recovery</title>
<p id="Par13">Heart rate recovery is characterized by increased parasympathetic tone followed by sympathetic withdrawal, which follows an inversed gradient pattern compared to heart rate increase [<xref ref-type="bibr" rid="CR19">19</xref>]. It was elegantly shown in a dual-blockade study that especially parasympathetic reactivation is essential for interindividual differences in heart rate recovery [<xref ref-type="bibr" rid="CR64">64</xref>]. However, the exact mechanisms underlying these differences remain to be determined. Twin, family, and GWA studies estimated the genetic component to interindividual differences of heart rate recovery after one minute to range between 0.12 and 0.60 (Table <xref ref-type="table" rid="Tab1">1</xref>). Therefore, genetic studies may yield novel insights into heart rate recovery. All genetic determinants investigated for their potential causal role in interindividual differences in heart rate recovery are summarized in Table <xref ref-type="table" rid="Tab3">3</xref> and are discussed below. An illustration of possible causal genes and how they are supposed to influence acute heart rate recovery after exercise is shown in Fig. <xref ref-type="fig" rid="Fig2">2</xref>.<fig id="Fig2"><label>Fig. 2</label><caption><p>Graphical representation of genes (shown in italic) involved in acute heart rate recovery after exercise grouped by working mechanism (shown in bold). The left and left upper part of the figure shows the nervous system. The middle upper part zooms in on a parasympathetic neuron of the vagus nerve (twice) and its synapse. Note that although we zoom in on the brain stem (which is the main location of parasympathetic nuclei that innervate the vagus nerve), we actually show a peripheral parasympathetic neuron of the vagus nerve. The heart is displayed on the right; the upper right of the figure shows the aorta with next to it a pacemaker cell in the cardiac sinus node. In the middle of the figure, below, we zoom in on cardiac tissue and receptors. Cholinergic receptors and enzymes are shown in light blue and glutamate receptors in yellow. Sodium and potassium channels are shown in red and pink, respectively</p></caption><graphic id="MO2" xlink:href="18_2019_3079_Fig2_HTML"></graphic></fig></p>
<p id="Par14">Initially, the same candidate genes were proposed for heart rate recovery as for heart rate increase. For example, the <italic>ACE</italic> gene was found to be related to heart rate recovery in one candidate gene study as well [<xref ref-type="bibr" rid="CR22">22</xref>]. Another study found <italic>ADRA1B</italic> and <italic>ADRA2B</italic> to be associated with heart rate recovery (Table <xref ref-type="table" rid="Tab3">3</xref>) [<xref ref-type="bibr" rid="CR12">12</xref>]. The association between <italic>ADRA2B</italic> gene and heart rate recovery was also found in another candidate gene study [<xref ref-type="bibr" rid="CR65">65</xref>]. Other studies focused primarily on the parasympathetic nervous system represented by the <italic>CHRM2</italic> gene. The minor alleles of the rs324640 and rs8191992 SNPs found in <italic>CHRM2</italic> region were found to be associated with a lower heart rate recovery in the general population [<xref ref-type="bibr" rid="CR66">66</xref>] and in patients with a history of myocardial infarction [<xref ref-type="bibr" rid="CR67">67</xref>]. In addition, these minor alleles increased chances of death to coronary artery disease in the latter group [<xref ref-type="bibr" rid="CR67">67</xref>].</p>
<p id="Par15">The problem of biased selection of candidate genes has been solved by conducting GWASs as previously stated. The first GWAS on the acute heart rate response to exercise found heart rate recovery measured 3 min post-exercise to be associated with <italic>PRKAG2,</italic> though this association did not reach genome-wide significance. <italic>PRKAG2</italic> is involved in the regulation of ATP restoration after periods of ATP depletion and therefore might influence the return of heart rate to its initial state (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig2">2</xref>).</p>
<p id="Par16">As previously mentioned, sample size was drastically increased in the two recent studies in the UK Biobank [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Some differences between both studies have been discussed earlier (i.e., sample size and genome-wide significant threshold). Concerning heart rate recovery, it is worth mentioning that the phenotype definition was not equal between both studies. The study of Ramirez et al. [<xref ref-type="bibr" rid="CR15">15</xref>] determined heart rate recovery traditionally as the difference between maximum heart rate and heart rate approximately 1 min after cessation of exercise. The study of Verweij et al. defined heart rate recovery at five time points, which included the differences between maximum heart rate and heart rate after 50, 40, 30, 20, and 10 s after exercise. This includes heart rate recovery at earlier time points (i.e., 10 s), which was recently established to be a superior predictor of outcome of all-cause mortality and death by coronary artery disease [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par17">Interestingly, both studies found the previously investigated candidate gene <italic>CHRM2</italic> to be associated with heart rate recovery [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. <italic>CHRM2</italic> encodes M2R, the main muscarinic cholinergic receptor in the heart. This receptor is known for both its negative chronotropic and inotropic effects after binding with acetylcholine released by postganglionic parasympathetic nerves (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR68">68</xref>]. The role of the parasympathetic nervous system in interindividual differences in heart rate recovery is additionally highlighted by the <italic>ACHE</italic> gene that was found in both studies. <italic>ACHE</italic> encodes for acetylcholinesterase, an enzyme which breaks down acetylcholine in the synaptic cleft of postganglionic parasympathetic nerves [<xref ref-type="bibr" rid="CR69">69</xref>]. An increase of acetylcholinesterase would therefore cause an attenuated heart rate recovery by decreasing parasympathetic reactivation. Other genes that were found in both studies were <italic>SYT10, CNTN3, PAX2, CAV2, MED13L, RNF220,</italic> and <italic>NDUFA11</italic> (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig2">2</xref>)<italic>. SYT10</italic> encodes a Ca<sup>2+</sup> sensor synaptotagmin 10 that triggers IGF-1 exocytosis, which, in turn, protects neurons from degeneration. <italic>SYT10</italic> might play an important role in the regulation of heart rate, as it was found to be associated with resting heart rate [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], heart rate increase [<xref ref-type="bibr" rid="CR15">15</xref>], and heart rate variability [<xref ref-type="bibr" rid="CR60">60</xref>] as well. <italic>CNTN3</italic> belongs to a group of glycosylphosphatidyl-anchored cell adhesion molecules that are mostly found in neurons [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Because of its similarity with <italic>TAG</italic>-<italic>1</italic>, it is thought to have an important function in neuronal outgrowth and wiring of the nervous system [<xref ref-type="bibr" rid="CR70">70</xref>–<xref ref-type="bibr" rid="CR72">72</xref>]. In the study of Ramirez et al. it was found that the allele of one SNP decreased heart rate recovery and increased <italic>CNTN3</italic> expression levels in the nucleus accumbens [<xref ref-type="bibr" rid="CR15">15</xref>]. Since heart rate recovery is mainly influenced by the parasympathetic nervous system [<xref ref-type="bibr" rid="CR64">64</xref>], it was hypothesized that CNTN3 may also be relevant to cardiac parasympathetic modulation [<xref ref-type="bibr" rid="CR15">15</xref>]. However, it is more likely to be associated with cardiac sympathetic modulation, since morphology of the nucleus accumbens has been shown to be correlated with cardiac sympathetic index [<xref ref-type="bibr" rid="CR73">73</xref>]. <italic>PAX2</italic> is known to be the first gene to be expressed in the mid- and hindbrain during embryonal developments in mice [<xref ref-type="bibr" rid="CR74">74</xref>] and can be found in the hindbrain in the early stages of embryo development in humans as well [<xref ref-type="bibr" rid="CR48">48</xref>]. The hindbrain includes the nucleus tractus solitarius, nucleus ambiguous, and dorsal nucleus of the vagus, which are known to mainly influence cardiac parasympathetic innervation of the heart through vagus nerve stimulation [<xref ref-type="bibr" rid="CR75">75</xref>]. Less is known about <italic>CAV2</italic>, which was found to be associated with heart rate response to exercise as well. However, one study pointed out that <italic>CAV2</italic> is necessary for differentiation of dorsal root ganglion cells during the early differentiating programs [<xref ref-type="bibr" rid="CR51">51</xref>]. The function of <italic>MED13L</italic> is unclear as well, but knockdown in zebrafish caused abnormal neural-crest cell migration [<xref ref-type="bibr" rid="CR76">76</xref>]. This is supported by clinical characteristics in humans with <italic>MED13L</italic> mutations, which can be characterized by intellectual disabilities, developmental delay, and craniofacial anomalies [<xref ref-type="bibr" rid="CR77">77</xref>]. <italic>RNF220</italic> functions as an E3 ubiquitin ligase, which determines protein target specificity during posttranslational ubiquitination [<xref ref-type="bibr" rid="CR53">53</xref>]. A possible link with heart rate recovery originates from the involvement of <italic>RNF220</italic> in the canonical WNT signalling cascade. In a knockdown study, <italic>RNF220</italic> was shown to stabilize β-catenin by interacting with ubiquitin-specific peptidase Usp7 [<xref ref-type="bibr" rid="CR54">54</xref>]. This stabilizing function is important, because the WNT/β-catenin signalling pathway is involved in embryonic cardiac development [<xref ref-type="bibr" rid="CR78">78</xref>], the development of cardiac disease [<xref ref-type="bibr" rid="CR79">79</xref>–<xref ref-type="bibr" rid="CR81">81</xref>], and in cardiac repair [<xref ref-type="bibr" rid="CR80">80</xref>]. <italic>NDUFA11</italic> is an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase complex I. In humans, a splice‐site mutation in this gene is known to cause mitochondrial complex I deficiency. This can cause a wide range of disorders, including encephalocardiomyopathy [<xref ref-type="bibr" rid="CR82">82</xref>]. Recently, it was shown that downregulation of <italic>NDUFA11</italic> by small interfering RNA reduced ATP production and increased mitochondria reactive oxygen species production in cardiac mitochondria of mice [<xref ref-type="bibr" rid="CR83">83</xref>]. <italic>NDUFA11</italic> was found to be associated with heart rate variability as well, suggesting that it is an important factor in causing differences between individuals’ heart rate response [<xref ref-type="bibr" rid="CR60">60</xref>].</p>
<p id="Par18">Other candidate genes found in one of the GWASs provide a biological hypothesis for their possible causal role in interindividual differences in heart rate recovery as well. These genes include <italic>CCDC141, BCL11A, KCNH8, ALG10B, GNG11, GRIK2,</italic> and <italic>NEGR1. CCDC141</italic> is a gene that plays a central role in neuronal development [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. In fact, in utero knockdown of <italic>CCDC141</italic> in mice resulted in impaired radial migration in [<xref ref-type="bibr" rid="CR44">44</xref>]. The same applies to <italic>BCL11A</italic>, which encodes a C2H2-type zinc-finger protein that is involved in neuronal development. Studies in mice have shown that slowed migration of neurons upon knockdown resulted in microcephaly with decreased brain volume [<xref ref-type="bibr" rid="CR84">84</xref>], particularly affecting the limbic system [<xref ref-type="bibr" rid="CR85">85</xref>]. Within the human brain, it is most highly expressed in the caudate nucleus followed by hippocampus [<xref ref-type="bibr" rid="CR86">86</xref>]. In humans, different de novo heterozygous mutations have been found to cause developmental disorder with persistence of fetal haemoglobin [<xref ref-type="bibr" rid="CR85">85</xref>]. <italic>KCNH8</italic> encodes a voltage-gated potassium channel. It is mainly expressed in the central nervous system and is involved in the regulation of neuronal excitation (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR87">87</xref>–<xref ref-type="bibr" rid="CR89">89</xref>]. <italic>ALG10B</italic> is involved in potassium regulation, as well, since it is a potassium channel regulator that couples to <italic>KCNH2</italic>. However, it is more involved in cardiac tissue than neuronal tissue and is known for its influence on heart rhythm. Upon binding with <italic>KCNH2,</italic> it reduces sensitivity to classic proarrhythmic drug blockade [<xref ref-type="bibr" rid="CR90">90</xref>]. <italic>GNG11</italic> encodes the γ11 subunit of the heterotrimeric G protein complex Gαβγ [<xref ref-type="bibr" rid="CR91">91</xref>]. <italic>GNG11</italic> is just as <italic>RGS6</italic> thought to be involved in GIRK activation and was found to be associated with heart rate variability [<xref ref-type="bibr" rid="CR60">60</xref>] as well. In this study, it was hypothesized that variations in this gene lower the availability of the γ11 subunit, thereby reducing Gαβγ component-induced GIRK activation [<xref ref-type="bibr" rid="CR60">60</xref>]. This would lead to decreased heart rate variability through attenuated response to changes in cardiac vagal activity [<xref ref-type="bibr" rid="CR60">60</xref>]. If true, the same would apply for heart rate recovery; decreased response to cardiac vagal reactivation after exercise would translate to blunted heart rate recovery. In addition, another mutation in the <italic>RGS6</italic> gene in humans was shown to decrease susceptibility to the long QT syndrome [<xref ref-type="bibr" rid="CR92">92</xref>]. <italic>GRIK2</italic> encodes a glutamate receptor that is mostly expressed in the human cerebral and cerebellar cortices [<xref ref-type="bibr" rid="CR93">93</xref>]. Here, it is involved in neuronal excitation and plays an important role in a variety of normal neurophysiologic processes. Neuronal Growth Regulator 1 (<italic>NEGR1</italic>) is essential for neuronal morphology and, just as <italic>CNTN3</italic>, has been shown to regulate neurite outgrowth (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig2">2</xref>) [<xref ref-type="bibr" rid="CR94">94</xref>]. Perhaps because of this essential function, <italic>NEGR1</italic> has been associated with many polygenetic traits, including body mass index, years of education, and physical activity.</p>
<p id="Par19">Heart rate increase and recovery share a high genetic correlation and it is therefore likely that there is overlap in genes that were found for both aspects of the heart rate response to exercise [<xref ref-type="bibr" rid="CR14">14</xref>]. <italic>SNCAIP, SOX5, RGS6,</italic> and <italic>MCTP2</italic> genes were already discussed for heart rate increase during exercise because of their stronger association with this phenotype.</p>
<p id="Par20"><italic>BCAT1, CLPB, PRDM6, SKAP,</italic> and <italic>SERINC2</italic> are also shown in Table <xref ref-type="table" rid="Tab3">3</xref>, but have not been discussed yet. To our knowledge, these genes could not be linked to heart rate recovery after exercise on a biological basis so far.</p>
</sec>
</sec>
<sec id="Sec5">
<title>Long-term modification of the heart rate response to exercise</title>
<sec id="Sec6">
<title>Heart rate increase</title>
<p id="Par21">Regular endurance exercise training is known to shift the cardiac autonomic balance towards vagal dominance [<xref ref-type="bibr" rid="CR10">10</xref>] and, as a consequence, diminish submaximal heart rate when an individual cycles at the same intensity [<xref ref-type="bibr" rid="CR11">11</xref>]. Large interindividual differences were observed for submaximal heart rate training response [<xref ref-type="bibr" rid="CR95">95</xref>] and heritability analysis estimated a genetic component ranging between 0.34 and 0.36 (Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Therefore, several studies were conducted to gain insights in the causes of these interindividual differences. The first study in the HERITAGE family cohort found a heritability of 0.34 for exercise heart rate changes to regular training, with the strongest linkage on chromosome 2q33.3-q34 [<xref ref-type="bibr" rid="CR17">17</xref>]. Next, this region was fine-mapped and it was found that the <italic>CREB1</italic> gene locus was strongly associated with submaximal exercise heart rate training response [<xref ref-type="bibr" rid="CR96">96</xref>]. Nonetheless, it only explained 5.45% of the 34% heritability [<xref ref-type="bibr" rid="CR96">96</xref>].</p>
<p id="Par22">To gain further insights in the genes causing the remaining fraction of its heritability, a GWAS was performed in the HERITAGE family cohort. In this study, nine SNPs were identified and accounted for the total of 34% heritability of exercise-induced changes to heart rate increase [<xref ref-type="bibr" rid="CR97">97</xref>]. The most significantly associated SNP was linked to the <italic>YWHAQ</italic> gene (Table <xref ref-type="table" rid="Tab4">4</xref>). <italic>YWHAQ</italic> is mostly expressed in the brain, heart, and pancreas [<xref ref-type="bibr" rid="CR98">98</xref>], and its main function is apoptosis and cell proliferation. It was shown that the cardiac-specific mutated <italic>YWHAQ</italic> gene leads to increased pathological ventricular remodelling with increased cardiomyocyte apoptosis after experimental myocardial infarction [<xref ref-type="bibr" rid="CR99">99</xref>]. It can be hypothesized that mutations in the <italic>YWHAQ</italic> gene lead to similar pathological cardiac remodelling after exercise training, causing diminished exercise-induced changes to heart rate increase. However, a neurological causal pathway cannot be ruled out, since the same mechanism could apply to neuronal remodelling needed to attenuate heart rate increase after regular exercise training [<xref ref-type="bibr" rid="CR11">11</xref>].The <italic>CREB1</italic> gene (Table <xref ref-type="table" rid="Tab4">4</xref>) was significantly associated with submaximal heart rate response to exercise training as well [<xref ref-type="bibr" rid="CR97">97</xref>]. In this study, it was hypothesized that <italic>CREB1</italic> altered the exercise-induced changes in heart rate increase due to its effect on either cardiac [<xref ref-type="bibr" rid="CR100">100</xref>] or neuronal memory [<xref ref-type="bibr" rid="CR101">101</xref>]. Cardiac memory is a phenomenon in which an altered T wave on electrocardiogram can be seen when sinus rhythm restarts after a period of abnormal rhythm, for example, after ventricular pacing or arrhythmia [<xref ref-type="bibr" rid="CR100">100</xref>]. The other hypothesis involving neuronal memory fits in our current understanding that neuron biology is of great importance in the heart rate response to exercise. Neuronal memory or long-term potentiation is a form of synaptic plasticity in which there is a long-lasting increase of synaptic strength in case the synapse is highly active. It could be hypothesized that regular exercise causes an increase of synaptic strength of parasympathetic neurons, thus altering the heart rate increase during exercise. However, <italic>CREB1</italic> encodes a transcription factor that regulates many mechanisms in the body and its association with memory does not imply causality. A recent editorial rightfully addressed the fact that the same allele in another study was found to increase the rise of temperature [<xref ref-type="bibr" rid="CR102">102</xref>] and, therefore, might decrease subjective liking of exercise training, potentially diminishing motivation [<xref ref-type="bibr" rid="CR103">103</xref>].<table-wrap id="Tab4"><label>Table 4</label><caption><p>Summary of genes involved in the long-term heart response to exercise</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">Variant</th><th align="left">Chromosome/position</th><th align="left"><italic>P</italic> value</th><th align="left">Type of study</th><th align="left">Training schedule</th><th align="left">Type of exercise test</th><th align="left">Population</th><th align="left">Author; year</th></tr></thead><tbody><tr><td align="left" colspan="9">Heart rate increase</td></tr><tr><td align="left"> CREB1<sup>a</sup></td><td align="left">rs2253206</td><td align="left">2:208100223</td><td align="left">1.6 × 10<sup>−5</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> GCH1<sup>a</sup></td><td align="left">rs2057368</td><td align="left">14:54373759</td><td align="left">5.6 × 10<sup>−5</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> GPRIN3<sup>a</sup></td><td align="left">rs1560488</td><td align="left">4:90444858</td><td align="left">3.3 × 10<sup>−5</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> RBPMS<sup>a</sup></td><td align="left">rs2979481</td><td align="left">8:30382328</td><td align="left">3.8 × 10<sup>−6</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> MYLIP<sup>a</sup></td><td align="left">rs909562</td><td align="left">6:16238312</td><td align="left">3.2 × 10<sup>−5</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> OR6N2<sup>a</sup></td><td align="left">rs857838</td><td align="left">1:157017174</td><td align="left">7.6 × 10<sup>−5</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> PIWIL1<sup>a</sup></td><td align="left">rs4759659</td><td align="left">12:129403241</td><td align="left">5.7 × 10<sup>−5</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> TFEC<sup>a</sup></td><td align="left">rs10248479</td><td align="left">7:115395591</td><td align="left">3.4 × 10<sup>−5</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30- 50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left"> YWHAQ<sup>a</sup></td><td align="left">rs6432018</td><td align="left">2:9639347</td><td align="left">8.1 × 10<sup>−7</sup> </td><td align="left">GWAS</td><td align="left">20 weeks, 3 times a day, 30–50 min at submaximal HR</td><td align="left">Submaximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Rankinen et al. (2012) [<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td align="left" colspan="9">Heart rate recovery</td></tr><tr><td align="left"> CHRM2<sup>b</sup> </td><td align="left">rs324640</td><td align="left">7:136146251 </td><td align="left">0.008</td><td align="left">Candidate</td><td align="left">2 weeks, 5 times a week, 40 min at submaximal HR</td><td align="left">Maximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Hautala (2006) [<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td align="left"> CHRM2<sup>b</sup> </td><td align="left">rs8191992 </td><td align="left">7:136158563 </td><td align="left">0.005</td><td align="left">Candidate</td><td align="left">2 weeks, 5 times a week, 40 min at submaximal HR</td><td align="left">Maximal bicycle</td><td align="left">Healthy, but sedentary</td><td align="left">Hautala (2006) [<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr></tbody></table><table-wrap-foot><p>Genes found to be associated with changes in training-induced changes to heart rate increase and recovery are shown in alphabetical order. Variant stands for either a SNP or deletion/insertion mutation. Candidate stands for candidate gene study. GWAS stands for genome-wide association study</p><p><sup>a</sup>Allele frequencies and betas are not mentioned in this study and direction (in- or decrease of response to training) can, therefore, not be determined</p><p><sup>b</sup>Minor alleles of rs324640 and rs8191992 (respectively, A and C) decreased heart rate recovery</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec7">
<title>Heart rate recovery</title>
<p id="Par23">On the other hand, heart rate recovery increases when the cardiac autonomic balance shifts towards vagal dominance after regular endurance training [<xref ref-type="bibr" rid="CR10">10</xref>]. Little research has been performed on the genetics of training-induced changes to heart rate recovery, although a heritable component has been suggested [<xref ref-type="bibr" rid="CR66">66</xref>]. To our knowledge, only one study has been conducted on this subject. In this candidate gene study, it was found that the <italic>CHRM2</italic> gene (Table <xref ref-type="table" rid="Tab4">4</xref>) is linked to long-term modification of heart rate recovery to exercise training as well [<xref ref-type="bibr" rid="CR66">66</xref>]. Participants who had a the minor alleles of the rs324640 and rs8191992 SNPs were not only found to have a lower acute heart rate recovery, but also showed less increase in heart rate recovery after regular endurance training. As previously mentioned, <italic>CHRM2</italic> encodes the muscarinic acetylcholine receptor M2R and, upon activation, causes a negative chronotropic and inotropic response. It therefore seems that genetic variation in <italic>CHRM2</italic> not only causes interindividual differences in acute heart rate recovery [<xref ref-type="bibr" rid="CR68">68</xref>], but also in long-term modifications. A full overview of the genes discussed for the long-term heart rate response to exercise can be found in Table <xref ref-type="table" rid="Tab4">4</xref>.</p>
</sec>
</sec>
<sec id="Sec8">
<title>Association of heart rate response to exercise-related genes with other traits</title>
<p id="Par24">We assessed the association of described genes with other traits in publicly available GWASs using the GWAS catalogue (Online Resource 1). In short, the candidate causal genes that were associated with both heart rate increase and recovery were also associated with resting heart rate (<italic>CCDC141</italic>, <italic>RGS6</italic>, <italic>RNF220</italic>, <italic>SCN10A</italic>, and <italic>SYT10</italic>), heart rate variability (<italic>CCDC141</italic>, <italic>RGS6</italic>, <italic>RNF220</italic>, and <italic>SYT10</italic>), blood pressure (<italic>CCDC141</italic> and <italic>PAX2</italic>), atrial fibrillation (<italic>CAV2</italic> and <italic>SCN10A</italic>), coronary artery disease (<italic>CAV2</italic> and <italic>SCN10A</italic>), and ECG traits including the PR interval (<italic>CAV2</italic> and <italic>SCN10A</italic>), QRS duration, and the Brugada syndrome (both <italic>SN10A</italic>).</p>
<p id="Par25">Some genes that were only associated with heart rate increase during exercise were found to be associated with resting heart rate and heart rate variability (<italic>PPIL1</italic>), blood pressure (<italic>ADRB1</italic>, <italic>ACE</italic>, <italic>NOS3</italic>, and <italic>HMGA2</italic>), atrial fibrillation (<italic>MCTP2</italic> and <italic>NOS3</italic>), exercise treadmill test and lung function (both <italic>RYR2</italic>). Similarly, some of the heart rate recovery genes were also associated with resting heart rate (<italic>ACHE</italic> and <italic>GNG11</italic>), heart rate variability (<italic>GNG11</italic> and <italic>NDUFA11</italic>), blood pressure (<italic>PRDM6</italic>, <italic>PRKAG2</italic>, and <italic>CHRM2</italic>), QRS duration, (<italic>PRDM6</italic>), atrial fibrillation and coronary artery disease (<italic>BCL11A</italic>, <italic>PRDM6</italic>), and obesity and vigorous physical activity levels (both <italic>NEGR1</italic>).</p>
</sec>
<sec id="Sec9">
<title>Future directions</title>
<p id="Par26">Improvement of prevention and treatment of disease in the human health sector is the ultimate application of novel knowledge found by genetic studies and future research should be performed to achieve this goal <bold>(</bold>Fig. <xref ref-type="fig" rid="Fig3">3</xref>) [<xref ref-type="bibr" rid="CR104">104</xref>]. Functional follow-up of findings obtained by GWAS will be necessary to gain insights in how likely causal genes affect the heart rate response to exercise [<xref ref-type="bibr" rid="CR104">104</xref>]. Most genes that were prioritized so far have a plausible biological mechanism in which they influence the heart rate response to exercise. However, the exact effect of all genes on exercise-induced heart rate changes could be validated in an experimental setting (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). One possible method is to perform functional experiments in cardiomyocytes obtained from embryonic stem cells [<xref ref-type="bibr" rid="CR105">105</xref>]. In cardiomyocytes, human diseases and risk factors with their underlying genetic contribution can be created in vitro [<xref ref-type="bibr" rid="CR105">105</xref>]. Since cardiomyocyte cell cultures can beat spontaneously [<xref ref-type="bibr" rid="CR105">105</xref>], simulating the effect of this genetic contribution allows for investigation of the acute heart rate response to pacing from resting to exercise heart rate levels in small cell cultures. In addition, by simulating the effect of this genetic contribution, drugs can be screened against an individual’s full genetic backgrounds to discover information on cardiotoxicity for each individual. This could potentially give insights in the development of personalized medicine strategies for heart rate modification [<xref ref-type="bibr" rid="CR106">106</xref>], which is an essential strategy in the treatment of coronary artery disease [<xref ref-type="bibr" rid="CR107">107</xref>] and heart failure (Fig. <xref ref-type="fig" rid="Fig3">3</xref>) [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. Genes known to affect cardiac de- and repolarisation (<italic>RYR2</italic>, <italic>ALG10B,</italic> and <italic>SCN10A</italic>) or GIRK channels in the cardiac sinus node (<italic>RGS6</italic> and <italic>GNG11</italic>) could be of interest to study in this setting. Recent development in the generation of spinal human cord neural cells could provide the same opportunity for investigating neuronal cell longevity including genes such as <italic>SCNAIP</italic>, <italic>POP4,</italic> and <italic>SYT10</italic> [<xref ref-type="bibr" rid="CR110">110</xref>]. Complex neurological mechanisms at the interplay of the sympathetic and parasympathetic nervous system (i.e., <italic>KCNH8</italic> and <italic>GRIK2</italic>) or neuronal development (i.e., <italic>SOX5</italic>, <italic>PAX2,</italic> and <italic>BCL11A</italic>) are more difficult to investigate using this method. This can be solved by investigating these genes using in vivo models of animals that share a high percentage of their genomic pattern with humans, including mice [<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>], fruit flies [<xref ref-type="bibr" rid="CR113">113</xref>], and zebrafish [<xref ref-type="bibr" rid="CR114">114</xref>] (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). For example, knockdown of <italic>RGS6</italic> [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]<italic>, MED13L</italic> [<xref ref-type="bibr" rid="CR76">76</xref>], and <italic>BCL11A</italic> [<xref ref-type="bibr" rid="CR85">85</xref>] has already provided insights in biological consequences of mutations in these genes.<fig id="Fig3"><label>Fig. 3</label><caption><p>Possible follow-up of GWAS on heart rate response to exercise. Cell models based on pluripotent stem cells provide a potential functional model to study GWAS findings using experimental manipulations that cannot be performed in vivo. Complex mechanisms of genetic interplay could be studied in animals that share a high percentage of their genomic sequence with humans, including mice, fruit flies, and zebrafishes. Tools such as gene knockdowns can be used to manipulate the genomes of these animal models. The ultimate application of knowledge initiated by GWAS findings in heart rate response to exercise lies in the improvement of primary and secondary prevention and personalized medicine to improve human health</p></caption><graphic id="MO3" xlink:href="18_2019_3079_Fig3_HTML"></graphic></fig></p>
<p id="Par27">Improvement of prevention of disease is another goal of genetic research. While accurate risk prediction might be relatively straightforward for mono- and oligogenic disease, this is more difficult for polygenic diseases such as coronary artery disease and heart failure. However, the knowledge on genetic variants obtained by GWAS can be used to construct genetic risk cores by summing the number of risk alleles weighted by the corresponding beta coefficients. Recently, it was shown that the polygenic risk score of coronary artery disease had the ability to identify 8.0% of the population at greater than threefold risk for coronary artery disease [<xref ref-type="bibr" rid="CR115">115</xref>]. These individuals can subsequently be selected for encouragement of behavioural lifestyle changes as relative effects of poor lifestyle were shown to be comparable between genetic risk groups [<xref ref-type="bibr" rid="CR116">116</xref>]. Similar to the traditional risk score models in which several traditional risk phenotypes are used to predict risk events, this could ultimately be performed for genetic risk score models as well. As previously stated, there is a large body of observational studies that links heart rate response to exercise to all-cause mortality and cardiovascular disease in healthy individuals and those with a history of cardiac disease [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. In this light, it would be interesting to see whether adding the polygenetic risk scores for the acute heart rate response to exercise into a genetic risk score model that includes the polygenetic risk score for the cardiovascular disease itself could improve detection of individuals at high risk of disease. However, it should be noted that both recent GWAS on the acute heart rate response to exercise did not find support for a genetic association with cardiovascular mortality [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The lack of an association in both studies might originate from the fact that a small replication cohort consisting of a relatively young and healthy population was used. The study of Verweij et al. [<xref ref-type="bibr" rid="CR14">14</xref>] did find a significant association between heart rate response to exercise and parental age as proxy for all-cause mortality. However, first, it is required to investigate whether there is a genetic association with cardiovascular disease and all-cause mortality, preferably in a larger independent cohort [<xref ref-type="bibr" rid="CR117">117</xref>].</p>
<p id="Par28">The evidence on long-term modification of the heart rate response to exercise is limited so far [<xref ref-type="bibr" rid="CR97">97</xref>]. If the genetics of the acute heart rate response to exercise can be used to predict cardiovascular mortality, the combination with information on the genetics of the long-term modification of the heart rate response to exercise could one day inform the choice of prevention strategy. For example, a high genetic risk score for a diminished acute response to exercise combined with a genetic risk score that indicates high training-induced changes to heart rate response could be an indicator of early primary or secondary prevention strategies (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). On the other hand, a high genetic risk score for a diminished acute response to exercise combined with a genetic risk score that indicates little training-induced changes could be an indication of early intervention through medication (Fig. <xref ref-type="fig" rid="Fig3">3</xref>).</p>
</sec>
<sec id="Sec10">
<title>Conclusion</title>
<p id="Par29">In the current review, we found a total of 10 genes associated with the acute heart rate response to exercise in candidate gene studies. Only one gene (<italic>CHRM2</italic>), related to heart rate recovery, was replicated in recent GWASs. Additional 17 candidate causal genes were identified for heart rate increase and 26 for heart rate recovery in these GWASs. Nine of these genes were associated with both acute heart rate increase and recovery during exercise. These genes can be broadly categorized into four categories: (1) development of the nervous system (<italic>CCDC141</italic>, <italic>PAX2</italic>, <italic>SOX5,</italic> and <italic>CAV2</italic>); (2) prolongation of neuronal life span (<italic>SYT10</italic>); (3) cardiac development (<italic>RNF220</italic> and <italic>MCTP2</italic>), and (4) cardiac rhythm (<italic>SCN10A</italic> and <italic>RGS6</italic>). Of the total of 43 genes, nine showed overlap with resting heart rate and heart rate variability, six with atrial fibrillation and coronary artery disease, two with ECG traits, and nine with blood pressure. The current findings support the idea that the autonomic nervous system is a major player in the regulation of the acute heart rate response to exercise. Heart rate recovery is especially influenced by parasympathetic nervous system genes (<italic>ACHE</italic> and <italic>CHRM2</italic>), in line with the previous research [<xref ref-type="bibr" rid="CR64">64</xref>]. Regarding the long-term response to exercise, heart rate increase during exercise was found to be mainly associated with genes involved in either cardiac or neuronal remodelling. Little evidence has been found for the long-term response of heart rate recovery to exercise, except for parasympathetic involvement. Future work will be required to translate these findings to preventive and therapeutic applications.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec11">
<p>Below is the link to the electronic supplementary material.
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="18_2019_3079_MOESM1_ESM.xlsx"><caption><p>Supplementary material 1 (XLSX 143 kb)</p></caption></media></supplementary-material></p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Publisher's Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Yordi J. van de Vegte and Balewgizie S. Tegegne have contributed equally to this work.</p>
</fn>
</fn-group>
<notes notes-type="funding-information">
<title>Funding</title>
<p>N. Verweij is supported by “Nederlandse Organisatie voor Wetenschappelijk Onderzoek” VENI grant (016.186.125) in support of research into ECG changes in response to exercise.</p>
</notes>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par30">The authors declare that they have no conflict of interest. Author N. Verweij is an employee of Genomics plc.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammond</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Froelicher</surname>
<given-names>VF</given-names>
</name>
</person-group>
<article-title>Normal and abnormal heart rate responses to exercise</article-title>
<source/>Prog Cardiovasc Dis
          <year>1985</year>
<volume>27</volume>
<fpage>271</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">2857054</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahrainy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Busey</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exercise training bradycardia is largely explained by reduced intrinsic heart rate</article-title>
<source/>Int J Cardiol
          <year>2016</year>
<volume>222</volume>
<fpage>213</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="pmid">27497097</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eppinga</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Hagemeijer</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of genomic loci associated with resting heart rate and shared genetic predictors with all-cause mortality</article-title>
<source/>Nat Genet
          <year>2016</year>
<volume>48</volume>
<fpage>1557</fpage>
<lpage>1563</lpage>
<pub-id pub-id-type="pmid">27798624</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fletcher</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Balady</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Amsterdam</surname>
<given-names>EA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association</article-title>
<source/>Circulation
          <year>2001</year>
<volume>104</volume>
<fpage>1694</fpage>
<lpage>1740</lpage>
<pub-id pub-id-type="pmid">11581152</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jouven</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Empana</surname>
<given-names>J-P</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heart-rate profile during exercise as a predictor of sudden death</article-title>
<source/>N Engl J Med
          <year>2005</year>
<volume>352</volume>
<fpage>1951</fpage>
<lpage>1958</lpage>
<pub-id pub-id-type="pmid">15888695</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCrory</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Berkman</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Nolan</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Speed of heart rate recovery in response to orthostatic challenge novelty and significance</article-title>
<source/>Circ Res
          <year>2016</year>
<volume>119</volume>
<fpage>666</fpage>
<lpage>675</lpage>
<pub-id pub-id-type="pmid">27330018</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Vegte</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>van der Harst</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Verweij</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Heart rate recovery 10 seconds after cessation of exercise predicts death</article-title>
<source/>J Am Heart Assoc
          <year>2018</year>
<volume>7</volume>
<fpage>e008341</fpage>
<pub-id pub-id-type="pmid">29622586</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arena</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abella</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The prognostic value of the heart rate response during exercise and recovery in patients with heart failure: influence of beta-blockade</article-title>
<source/>Int J Cardiol
          <year>2010</year>
<volume>138</volume>
<fpage>166</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="pmid">18804882</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dresing</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Blackstone</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Pashkow</surname>
<given-names>FJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Usefulness of impaired chronotropic response to exercise as a predictor of mortality, independent of the severity of coronary artery disease</article-title>
<source/>Am J Cardiol
          <year>2000</year>
<volume>86</volume>
<fpage>602</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="pmid">10980208</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hautala</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Mäkikallio</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Kiviniemi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heart rate dynamics after controlled training followed by a home-based exercise program</article-title>
<source/>Eur J Appl Physiol
          <year>2004</year>
<volume>92</volume>
<fpage>289</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="pmid">15083365</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brubaker</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Kitzman</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Chronotropic incompetence: causes, consequences, and management</article-title>
<source/>Circulation
          <year>2011</year>
<volume>123</volume>
<issue>9</issue>
<fpage>1010</fpage>
<lpage>1020</lpage>
<pub-id pub-id-type="pmid">21382903</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingelsson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Vasan</surname>
<given-names>RS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heritability, linkage, and genetic associations of exercise treadmill test responses</article-title>
<source/>Circulation
          <year>2007</year>
<volume>115</volume>
<fpage>2917</fpage>
<lpage>2924</lpage>
<pub-id pub-id-type="pmid">17548724</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nederend</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schutte</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Bartels</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heritability of heart rate recovery and vagal rebound after exercise</article-title>
<source/>Eur J Appl Physiol
          <year>2016</year>
<volume>116</volume>
<fpage>2167</fpage>
<lpage>2176</lpage>
<pub-id pub-id-type="pmid">27614881</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verweij</surname>
<given-names>N</given-names>
</name>
<name>
<surname>van de Vegte</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>van der Harst</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Genetic study links components of the autonomous nervous system to heart-rate profile during exercise</article-title>
<source/>Nat Commun
          <year>2018</year>
<volume>9</volume>
<fpage>898</fpage>
<pub-id pub-id-type="pmid">29497042</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramírez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Duijvenboden</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ntalla</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Thirty loci identified for heart rate response to exercise and recovery implicate autonomic nervous system</article-title>
<source/>Nat Commun
          <year>2018</year>
<volume>9</volume>
<fpage>1947</fpage>
<pub-id pub-id-type="pmid">29769521</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rice</surname>
<given-names>T</given-names>
</name>
<name>
<surname>An</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gagnon</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heritability of HR and BP response to exercise training in the HERITAGE Family Study</article-title>
<source/>Med Sci Sports Exerc
          <year>2002</year>
<volume>34</volume>
<fpage>972</fpage>
<lpage>979</lpage>
<pub-id pub-id-type="pmid">12048324</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pérusse</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rankinen</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familial aggregation of exercise heart rate and blood pressure in response to 20 weeks of endurance training: the HERITAGE family study</article-title>
<source/>Int J Sports Med
          <year>2003</year>
<volume>24</volume>
<fpage>57</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">12582953</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visscher</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Wray</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>10 years of GWAS discovery: biology, function, and translation</article-title>
<source/>Am J Hum Genet
          <year>2017</year>
<volume>101</volume>
<fpage>5</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">28686856</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coote</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Recovery of heart rate following intense dynamic exercise</article-title>
<source/>Exp Physiol
          <year>2010</year>
<volume>95</volume>
<fpage>431</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="pmid">19837772</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saghiv</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sagiv</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Response of left ventricular volumes and ejection fraction during different modes of exercise in health and CAD patients</article-title>
<source/>Int J Clin Cardiol Res
          <year>2017</year>
<volume>1</volume>
<fpage>51</fpage>
<lpage>56</lpage>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montgomery</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hemingway</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human gene for physical performance</article-title>
<source/>Nature
          <year>1998</year>
<volume>393</volume>
<fpage>221</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="pmid">9607758</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voroshin</surname>
<given-names>IN</given-names>
</name>
<name>
<surname>Astratenkova</surname>
<given-names>IV</given-names>
</name>
</person-group>
<article-title>Dependence of endurance performance on ACE gene polymorphism in athletes</article-title>
<source/>Hum Physiol
          <year>2008</year>
<volume>34</volume>
<fpage>117</fpage>
<lpage>119</lpage>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roltsch</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Hand</surname>
<given-names>BD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>No association between ACE I/D polymorphism and cardiovascular hemodynamics during exercise in young women</article-title>
<source/>Int J Sports Med
          <year>2005</year>
<volume>26</volume>
<fpage>638</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="pmid">16158368</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCole</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>GE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Angiotensinogen M235T polymorphism associates with exercise hemodynamics in postmenopausal women</article-title>
<source/>Physiol Genomics
          <year>2002</year>
<volume>10</volume>
<fpage>63</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">12181363</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rankinen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pérusse</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gagnon</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study</article-title>
<source/>J Appl Physiol
          <year>2000</year>
<volume>88</volume>
<fpage>1029</fpage>
<lpage>1035</lpage>
<pub-id pub-id-type="pmid">10710400</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hand</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>McCole</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>MD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>NOS3 gene polymorphisms and exercise hemodynamics in postmenopausal women</article-title>
<source/>Int J Sports Med
          <year>2006</year>
<volume>27</volume>
<fpage>951</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="pmid">16761221</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zanzinger</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Role of nitric oxide in the neural control of cardiovascular function</article-title>
<source/>Cardiovasc Res
          <year>1999</year>
<volume>43</volume>
<fpage>639</fpage>
<lpage>649</lpage>
<pub-id pub-id-type="pmid">10690335</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieminen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lehtimäki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Laiho</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study</article-title>
<source/>J Appl Physiol
          <year>2006</year>
<volume>100</volume>
<fpage>507</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="pmid">16210433</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Defoor</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martens</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zielińska</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The CAREGENE study: polymorphisms of the β1-adrenoceptor gene and aerobic power in coronary artery disease</article-title>
<source/>Eur Heart J
          <year>2006</year>
<volume>27</volume>
<fpage>808</fpage>
<lpage>816</lpage>
<pub-id pub-id-type="pmid">16421173</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eisenach</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>McGuire</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Schwingler</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Arg16/Gly β 2 -adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise</article-title>
<source/>Physiol Genomics
          <year>2004</year>
<volume>16</volume>
<fpage>323</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="pmid">14665698</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altmüller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomewide scans of complex human diseases: true linkage is hard to find</article-title>
<source/>Am J Hum Genet
          <year>2001</year>
<volume>69</volume>
<fpage>936</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="pmid">11565063</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirschhorn</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Genome-wide association studies for common diseases and complex traits</article-title>
<source/>Nat Rev Genet
          <year>2005</year>
<volume>6</volume>
<fpage>95</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="pmid">15716906</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirschhorn</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>Genetic approaches to studying common diseases and complex traits</article-title>
<source/>Pediatr Res
          <year>2005</year>
<volume>57</volume>
<fpage>74R</fpage>
<lpage>77R</lpage>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasan</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Aragam</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study</article-title>
<source/>BMC Med Genet
          <year>2007</year>
<volume>8</volume>
<fpage>S2</fpage>
<pub-id pub-id-type="pmid">17903301</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiso</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Nava</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)</article-title>
<source/>Hum Mol Genet
          <year>2001</year>
<volume>10</volume>
<fpage>189</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="pmid">11159936</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsio</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Salamon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bagattin</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations</article-title>
<source/>Biochem Biophys Res Commun
          <year>2002</year>
<volume>299</volume>
<fpage>594</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="pmid">12459180</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Priori</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Memmi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia</article-title>
<source/>Circulation
          <year>2002</year>
<volume>106</volume>
<fpage>69</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">12093772</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huffman</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Examining the current standards for genetic discovery and replication in the era of mega-biobanks</article-title>
<source/>Nat Commun
          <year>2018</year>
<volume>9</volume>
<fpage>5054</fpage>
<pub-id pub-id-type="pmid">30498205</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Franck</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wolburg</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice</article-title>
<source/>Neurogenetics
          <year>2010</year>
<volume>11</volume>
<fpage>107</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="pmid">19760259</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synphilin-1 attenuates neuronal degeneration in the A53T -synuclein transgenic mouse model</article-title>
<source/>Hum Mol Genet
          <year>2010</year>
<volume>19</volume>
<fpage>2087</fpage>
<lpage>2098</lpage>
<pub-id pub-id-type="pmid">20185556</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarrous</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Eder</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Wesolowski</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Rpp14 and Rpp29, two protein subunits of human ribonuclease P</article-title>
<source/>RNA
          <year>1999</year>
<volume>5</volume>
<fpage>153</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">10024167</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abu-Zhayia</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Khoury-Haddad</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Guttmann-Raviv</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A role of human RNase P subunits, Rpp29 and Rpp21, in homology directed-repair of double-strand breaks</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>1002</fpage>
<pub-id pub-id-type="pmid">28432356</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raven</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Chapleau</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Blood pressure regulation XI: overview and future research directions</article-title>
<source/>Eur J Appl Physiol
          <year>2014</year>
<volume>114</volume>
<fpage>579</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="pmid">24463603</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sugita</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Inatome</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yanagi</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>CAMDI, a novel disrupted in schizophrenia 1 (DISC1)-binding protein, is required for radial migration</article-title>
<source/>J Biol Chem
          <year>2010</year>
<volume>285</volume>
<fpage>40554</fpage>
<lpage>40561</lpage>
<pub-id pub-id-type="pmid">20956536</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandon</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Linking neurodevelopmental and synaptic theories of mental illness through DISC1</article-title>
<source/>Nat Rev Neurosci
          <year>2011</year>
<volume>12</volume>
<fpage>707</fpage>
<lpage>722</lpage>
<pub-id pub-id-type="pmid">22095064</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Pontual</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mathieu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Golzio</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutational, functional, and expression studies of the TCF4 gene in pitt-hopkins syndrome</article-title>
<source/>Hum Mutat
          <year>2009</year>
<volume>30</volume>
<fpage>669</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="pmid">19235238</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sepp</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pruunsild</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Timmusk</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects</article-title>
<source/>Hum Mol Genet
          <year>2012</year>
<volume>21</volume>
<fpage>2873</fpage>
<lpage>2888</lpage>
<pub-id pub-id-type="pmid">22460224</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tellier</surname>
<given-names>A-L</given-names>
</name>
<name>
<surname>Amiel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delezoide</surname>
<given-names>A-L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of thePAX2 gene in human embryos and exclusion in the CHARGE syndrome</article-title>
<source/>Am J Med Genet
          <year>2000</year>
<volume>93</volume>
<fpage>85</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">10869107</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jabaudon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Molyneaux</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SOX5 controls the sequential generation of distinct corticofugal neuron subtypes</article-title>
<source/>Neuron
          <year>2008</year>
<volume>57</volume>
<fpage>232</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">18215621</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamb</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Neill</surname>
<given-names>NJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Haploinsufficiency of <italic>SOX5</italic> at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features</article-title>
<source/>Hum Mutat
          <year>2012</year>
<volume>33</volume>
<fpage>728</fpage>
<lpage>740</lpage>
<pub-id pub-id-type="pmid">22290657</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galbiati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Volonte</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1998</year>
<volume>95</volume>
<fpage>10257</fpage>
<lpage>10262</lpage>
<pub-id pub-id-type="pmid">9707634</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woitecki</surname>
<given-names>AMH</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>van Loo</surname>
<given-names>KMJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of synaptotagmin 10 as effector of NPAS4-mediated protection from excitotoxic neurodegeneration</article-title>
<source/>J Neurosci
          <year>2016</year>
<volume>36</volume>
<fpage>2561</fpage>
<lpage>2570</lpage>
<pub-id pub-id-type="pmid">26936998</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RNF220, an E3 ubiquitin ligase that targets Sin3B for ubiquitination</article-title>
<source/>Biochem Biophys Res Commun
          <year>2010</year>
<volume>393</volume>
<fpage>708</fpage>
<lpage>713</lpage>
<pub-id pub-id-type="pmid">20170641</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of β-catenin</article-title>
<source/>Mol Cell Biol
          <year>2014</year>
<volume>34</volume>
<fpage>4355</fpage>
<lpage>4366</lpage>
<pub-id pub-id-type="pmid">25266658</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Facer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Punjabi</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Abrari</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Localisation of SCN10A gene product Nav1.8 and novel pain-related ion channels in human heart</article-title>
<source/>Int Heart J
          <year>2011</year>
<volume>52</volume>
<fpage>146</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="pmid">21646736</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Maity</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RGS6, a modulator of parasympathetic activation in heart</article-title>
<source/>Circ Res
          <year>2010</year>
<volume>107</volume>
<fpage>1345</fpage>
<lpage>1349</lpage>
<pub-id pub-id-type="pmid">20864673</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wydeven</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Posokhova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RGS6, but not RGS4, is the dominant regulator of G protein signaling (RGS) modulator of the parasympathetic regulation of mouse heart rate</article-title>
<source/>J Biol Chem
          <year>2014</year>
<volume>289</volume>
<fpage>2440</fpage>
<lpage>2449</lpage>
<pub-id pub-id-type="pmid">24318880</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bower</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Allanson</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database</article-title>
<source/>Hum Mutat
          <year>2012</year>
<volume>33</volume>
<fpage>457</fpage>
<lpage>466</lpage>
<pub-id pub-id-type="pmid">22213154</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barua</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stellacci</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stella</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in PAX2 associate with adult-onset FSGS</article-title>
<source/>J Am Soc Nephrol
          <year>2014</year>
<volume>25</volume>
<fpage>1942</fpage>
<lpage>1953</lpage>
<pub-id pub-id-type="pmid">24676634</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nolte</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Munoz</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Tragante</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic loci associated with heart rate variability and their effects on cardiac disease risk</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<fpage>15805</fpage>
<pub-id pub-id-type="pmid">28613276</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camm</surname>
<given-names>AJMM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology</article-title>
<source/>Circulation
          <year>1996</year>
<volume>93</volume>
<fpage>1043</fpage>
<lpage>1065</lpage>
<pub-id pub-id-type="pmid">8598068</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ioannidis</surname>
<given-names>JPA</given-names>
</name>
<name>
<surname>Ntzani</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Trikalinos</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Contopoulos-Ioannidis</surname>
<given-names>DG</given-names>
</name>
</person-group>
<article-title>Replication validity of genetic association studies</article-title>
<source/>Nat Genet
          <year>2001</year>
<volume>29</volume>
<fpage>306</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="pmid">11600885</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Krumholz</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Lifton</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Spertus</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study</article-title>
<source/>JAMA
          <year>2007</year>
<volume>297</volume>
<fpage>1551</fpage>
<pub-id pub-id-type="pmid">17426274</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure</article-title>
<source/>J Am Coll Cardiol
          <year>1994</year>
<volume>24</volume>
<fpage>1529</fpage>
<lpage>1535</lpage>
<pub-id pub-id-type="pmid">7930286</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohli</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Diedrich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kannankeril</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise</article-title>
<source/>Physiol Genomics
          <year>2015</year>
<volume>47</volume>
<fpage>400</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="pmid">26058836</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hautala</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Heart rate recovery after maximal exercise is associated with acetylcholine receptor M2 (CHRM2) gene polymorphism</article-title>
<source/>AJP Hear Circ Physiol
          <year>2006</year>
<volume>291</volume>
<fpage>H459</fpage>
<lpage>H466</lpage>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hautala</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Tulppo</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Kiviniemi</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acetylcholine receptor M2 gene variants, heart rate recovery, and risk of cardiac death after an acute myocardial infarction</article-title>
<source/>Ann Med
          <year>2009</year>
<volume>41</volume>
<fpage>197</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="pmid">18979273</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brodde</surname>
<given-names>OE</given-names>
</name>
<name>
<surname>Michel</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Adrenergic and muscarinic receptors in the human heart</article-title>
<source/>Pharmacol Rev
          <year>1999</year>
<volume>51</volume>
<fpage>651</fpage>
<lpage>690</lpage>
<pub-id pub-id-type="pmid">10581327</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whittaker</surname>
<given-names>VP</given-names>
</name>
</person-group>
<article-title>The contribution of drugs and toxins to understanding of cholinergic function</article-title>
<source/>Trends Pharmacol Sci
          <year>1990</year>
<volume>11</volume>
<fpage>8</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">2408211</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolaienko</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Hammel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dubreuil</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural basis for interactions between contactin family members and protein-tyrosine phosphatase receptor type G in neural tissues</article-title>
<source/>J Biol Chem
          <year>2016</year>
<volume>291</volume>
<fpage>21335</fpage>
<lpage>21349</lpage>
<pub-id pub-id-type="pmid">27539848</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</name>
</person-group>
<article-title>Autism and brain development</article-title>
<source/>Cell
          <year>2008</year>
<volume>135</volume>
<fpage>396</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="pmid">18984148</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connelly</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Grady</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Mushinski</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Marcu</surname>
<given-names>KB</given-names>
</name>
</person-group>
<article-title>PANG, a gene encoding a neuronal glycoprotein, is ectopically activated by intracisternal A-type particle long terminal repeats in murine plasmacytomas</article-title>
<source/>Proc Natl Acad Sci USA
          <year>1994</year>
<volume>91</volume>
<fpage>1337</fpage>
<lpage>1341</lpage>
<pub-id pub-id-type="pmid">8108413</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruffle</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Coen</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Giampietro</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans</article-title>
<source/>Hum Brain Mapp
          <year>2018</year>
<volume>39</volume>
<fpage>381</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="pmid">29080228</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeffer</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Payer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reim</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The activation and maintenance of Pax2 expression at the mid-hindbrain boundary is controlled by separate enhancers</article-title>
<source/>Development
          <year>2002</year>
<volume>129</volume>
<fpage>307</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="pmid">11807024</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>DeSimone</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Asirvatham</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Innervation of the heart: an invisible grid within a black box</article-title>
<source/>Trends Cardiovasc Med
          <year>2016</year>
<volume>26</volume>
<fpage>245</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">26254961</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Utami</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Winata</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Hillmer</surname>
<given-names>AM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired development of neural-crest cell-derived organs and intellectual disability caused by MED13L haploinsufficiency</article-title>
<source/>Hum Mutat
          <year>2014</year>
<volume>35</volume>
<fpage>1311</fpage>
<lpage>1320</lpage>
<pub-id pub-id-type="pmid">25137640</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asadollahi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zweier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gogoll</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation</article-title>
<source/>Eur J Med Genet
          <year>2017</year>
<volume>60</volume>
<fpage>451</fpage>
<lpage>464</lpage>
<pub-id pub-id-type="pmid">28645799</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piven</surname>
<given-names>OO</given-names>
</name>
<name>
<surname>Winata</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling</article-title>
<source/>Exp Biol Med
          <year>2017</year>
<volume>242</volume>
<fpage>1735</fpage>
<lpage>1745</lpage>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakagawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Sumida</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of endothelial β-catenin signaling induces heart failure</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>25009</fpage>
<pub-id pub-id-type="pmid">27146149</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pahnke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Conant</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huyer</surname>
<given-names>LD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of Wnt regulation in heart development, cardiac repair and disease: a tissue engineering perspective</article-title>
<source/>Biochem Biophys Res Commun
          <year>2016</year>
<volume>473</volume>
<fpage>698</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="pmid">26626076</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foulquier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Daskalopoulos</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Lluri</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>WNT signaling in cardiac and vascular disease</article-title>
<source/>Pharmacol Rev
          <year>2018</year>
<volume>70</volume>
<fpage>68</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">29247129</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berger</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hershkovitz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shaag</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial complex I deficiency caused by a deleterious NDUFA11 mutation</article-title>
<source/>Ann Neurol
          <year>2008</year>
<volume>63</volume>
<fpage>405</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="pmid">18306244</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Javadov</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Elucidating the contribution of ETC complexes I and II to the respirasome formation in cardiac mitochondria</article-title>
<source/>Sci Rep
          <year>2018</year>
<volume>8</volume>
<fpage>17732</fpage>
<pub-id pub-id-type="pmid">30531981</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiegreffe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Peschkes</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bcl11a (Ctip1) controls migration of cortical projection neurons through regulation of Sema3c</article-title>
<source/>Neuron
          <year>2015</year>
<volume>87</volume>
<fpage>311</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">26182416</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Estruch</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BCL11A haploinsufficiency causes an intellectual disability syndrome and dysregulates transcription</article-title>
<source/>Am J Hum Genet
          <year>2016</year>
<volume>99</volume>
<fpage>253</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="pmid">27453576</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saiki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells</article-title>
<source/>Genomics
          <year>2000</year>
<volume>70</volume>
<fpage>387</fpage>
<lpage>391</lpage>
<pub-id pub-id-type="pmid">11161790</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koskela</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laiho</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kähönen</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Potassium channel KCNH2 K897T polymorphism and cardiac repolarization during exercise test: the Finnish Cardiovascular study</article-title>
<source/>Scand J Clin Lab Invest
          <year>2008</year>
<volume>68</volume>
<fpage>31</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">17852802</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zagotta</surname>
<given-names>WN</given-names>
</name>
</person-group>
<article-title>Molecular mechanism of voltage-dependent potentiation of KCNH potassium channels</article-title>
<source/>Elife
          <year>2017</year>
<volume>6</volume>
<fpage>e26355</fpage>
<pub-id pub-id-type="pmid">28443815</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Martinson</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Layden</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ether-à-go-go family voltage-gated K+ channels evolved in an ancestral metazoan and functionally diversified in a cnidarian-bilaterian ancestor</article-title>
<source/>J Exp Biol
          <year>2015</year>
<volume>218</volume>
<fpage>526</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="pmid">25696816</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kupershmidt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>IC-H</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines</article-title>
<source/>FASEB J
          <year>2003</year>
<volume>17</volume>
<fpage>2263</fpage>
<lpage>2265</lpage>
<pub-id pub-id-type="pmid">14525949</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilman</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>G Proteins: transducers of receptor-generated signals</article-title>
<source/>Annu Rev Biochem
          <year>1987</year>
<volume>56</volume>
<fpage>615</fpage>
<lpage>649</lpage>
<pub-id pub-id-type="pmid">3113327</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petersen</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>McFarland</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Stepanovic</surname>
<given-names>SZ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo identification of genes that modify ether-a-go-go-related gene activity in <italic>Caenorhabditis elegans</italic> may also affect human cardiac arrhythmia</article-title>
<source/>Proc Natl Acad Sci
          <year>2004</year>
<volume>101</volume>
<fpage>11773</fpage>
<lpage>11778</lpage>
<pub-id pub-id-type="pmid">15280551</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Contractor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mulle</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>Kainate receptors coming of age: milestones of two decades of research</article-title>
<source/>Trends Neurosci
          <year>2011</year>
<volume>34</volume>
<fpage>154</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="pmid">21256604</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pischedda</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Szczurkowska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cirnaru</surname>
<given-names>MD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A cell surface biotinylation assay to reveal membrane-associated neuronal cues: Negr1 regulates dendritic arborization</article-title>
<source/>Mol Cell Proteomics
          <year>2014</year>
<volume>13</volume>
<fpage>733</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="pmid">24382801</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilmore</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Stanforth</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Gagnon</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heart rate and blood pressure changes with endurance training: the HERITAGE family study</article-title>
<source/>Med Sci Sports Exerc
          <year>2001</year>
<volume>33</volume>
<fpage>107</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="pmid">11194095</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rankinen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Argyropoulos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CREB1 is a strong genetic predictor of the variation in exercise heart rate response to regular exercise: the HERITAGE family study</article-title>
<source/>Circ Cardiovasc Genet
          <year>2010</year>
<volume>3</volume>
<fpage>294</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="pmid">20407090</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rankinen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Sarzynski</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heritability of submaximal exercise heart rate response to exercise training is accounted for by nine SNPs</article-title>
<source/>J Appl Physiol
          <year>2012</year>
<volume>112</volume>
<fpage>892</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="pmid">22174390</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malaspina</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaushik</surname>
<given-names>N</given-names>
</name>
<name>
<surname>de Belleroche</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord</article-title>
<source/>J Neurochem
          <year>2000</year>
<volume>75</volume>
<fpage>2511</fpage>
<lpage>2520</lpage>
<pub-id pub-id-type="pmid">11080204</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lau</surname>
<given-names>JMC</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The 14-3-3tau phosphoserine-binding protein is required for cardiomyocyte survival</article-title>
<source/>Mol Cell Biol
          <year>2007</year>
<volume>27</volume>
<fpage>1455</fpage>
<lpage>1466</lpage>
<pub-id pub-id-type="pmid">17145769</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patberg</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Shvilkin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Plotnikov</surname>
<given-names>AN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cardiac memory: mechanisms and clinical implications</article-title>
<source/>Hear Rhythm
          <year>2005</year>
<volume>2</volume>
<fpage>1376</fpage>
<lpage>1382</lpage>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Z-Q</given-names>
</name>
</person-group>
<article-title>Transducer of regulated CREB and late phase long-term synaptic potentiation</article-title>
<source/>FEBS J
          <year>2007</year>
<volume>274</volume>
<fpage>3218</fpage>
<lpage>3223</lpage>
<pub-id pub-id-type="pmid">17565597</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pickering</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kiely</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Exercise genetics: seeking clarity from noise</article-title>
<source/>BMJ Open Sport Exerc Med
          <year>2017</year>
<volume>3</volume>
<fpage>e000309</fpage>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karoly</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Magnan</surname>
<given-names>RE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic influences on physiological and subjective responses to an aerobic exercise session among sedentary adults</article-title>
<source/>J Cancer Epidemiol
          <year>2012</year>
<volume>2012</volume>
<fpage>1</fpage>
<lpage>12</lpage>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wangler</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Drosophila and genome-wide association studies: a review and resource for the functional dissection of human complex traits</article-title>
<source/>Dis Model Mech
          <year>2017</year>
<volume>10</volume>
<fpage>77</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">28151408</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamel</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De Novo human cardiac myocytes for medical research: promises and challenges</article-title>
<source/>Stem Cells Int
          <year>2017</year>
<volume>2017</volume>
<fpage>1</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Matsa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Induced pluripotent stem cells: at the heart of cardiovascular precision medicine</article-title>
<source/>Nat Rev Cardiol
          <year>2016</year>
<volume>13</volume>
<fpage>333</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="pmid">27009425</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Benjamin</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Bonow</surname>
<given-names>RO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update</article-title>
<source/>J Am Coll Cardiol
          <year>2011</year>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponikowski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Voors</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Anker</surname>
<given-names>SD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure</article-title>
<source/>Eur Heart J
          <year>2016</year>
<volume>37</volume>
<fpage>2129</fpage>
<lpage>2200</lpage>
<pub-id pub-id-type="pmid">27206819</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swedberg</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Komajda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Böhm</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study</article-title>
<source/>Lancet
          <year>2010</year>
<volume>376</volume>
<fpage>875</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="pmid">20801500</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumamaru</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kadoya</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>AF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Generation and post-injury integration of human spinal cord neural stem cells</article-title>
<source/>Nat Methods
          <year>2018</year>
<volume>15</volume>
<fpage>723</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="pmid">30082899</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Mouse Genome Sequencing Consortium</collab>
<name>
<surname>Waterston</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Lindblad-Toh</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Initial sequencing and comparative analysis of the mouse genome</article-title>
<source/>Nature
          <year>2002</year>
<volume>420</volume>
<fpage>520</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="pmid">12466850</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Harst</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van Setten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Verweij</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>52 genetic loci influencing myocardial mass</article-title>
<source/>J Am Coll Cardiol
          <year>2016</year>
<volume>68</volume>
<fpage>1435</fpage>
<lpage>1448</lpage>
<pub-id pub-id-type="pmid">27659466</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bier</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Drosophila, the golden bug, emerges as a tool for human genetics</article-title>
<source/>Nat Rev Genet
          <year>2005</year>
<volume>6</volume>
<fpage>9</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="pmid">15630418</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Torroja</surname>
<given-names>CF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The zebrafish reference genome sequence and its relationship to the human genome</article-title>
<source/>Nature
          <year>2013</year>
<volume>496</volume>
<fpage>498</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="pmid">23594743</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khera</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Chaffin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aragam</surname>
<given-names>KG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations</article-title>
<source/>Nat Genet
          <year>2018</year>
<volume>50</volume>
<fpage>1219</fpage>
<lpage>1224</lpage>
<pub-id pub-id-type="pmid">30104762</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Said</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Verweij</surname>
<given-names>N</given-names>
</name>
<name>
<surname>van der Harst</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study</article-title>
<source/>JAMA Cardiol
          <year>2018</year>
<volume>3</volume>
<fpage>693</fpage>
<pub-id pub-id-type="pmid">29955826</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraft</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zeggini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ioannidis</surname>
<given-names>JPA</given-names>
</name>
</person-group>
<article-title>Replication in genome-wide association studies</article-title>
<source/>Stat Sci
          <year>2009</year>
<volume>1</volume>
<fpage>1</fpage>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>